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ABSTRACT 
 
Elizabeth Jane Cline: Application of Dynamic Combinatorial Chemistry to Identify New 
Compounds that Bind G-Quadruplex DNA & Probing the Role of the Cation-π Interaction 
Between the HP1 Chromodomain and Methylated Lysine Using Unnatural Amino Acids 
 (Under the direction of Marcey L. Waters) 
 
 
This dissertation discusses two different projects.  The first project involves the 
development of cyclic-peptide acridine conjugates in the effort to identify molecules that can 
selectively bind to and stabilize G-quadruplex DNA.  The second project seeks to probe the role 
of the cation-π interaction in the binding of the HP1 chromodomain to trimethylated lysine 9 of 
histone 3 (H3). 
In recent years, interest in the G-quadruplex DNA structure has increased enormously 
due to the unique physical properties of this secondary DNA structure as well as the presence of 
guanine-rich sequences in biologically functional regions of many genomes.  Given the 
propensity of G-quadruplex structures to control many biological functions, it has become 
desirable to identify small molecules that can bind to and stabilize G-quadruplexes.  This work 
aims to develop quadruplex ligands that exhibit selectively over not only duplex DNA but also 
over various quadruplex sequences.  It was believed that cyclic peptides could deliver selectivity 
for the quadruplex structure over duplex DNA while also providing the added advantages of 
mimicking native protein structure, displaying enhanced metabolic stability and possessing 
structural preorganization.  Using a strategy that has been developed in our lab, we propose 
screening libraries of cyclic peptides generated in situ using thiol-thioester exchange for dynamic 
combinatorial chemistry (DCC).  These libraries can efficiently be screen against different 
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quadruplex sequences as well as duplex DNA in order to determine the selectivity of each 
species. 
In the second project, we sought to characterize the noncovalent interactions responsible 
for the recognition of trimethylated lysine 9 of histone 3 by the aromatic pocket of the HP1 
chromodomain.  Lysine can exist in three distinct methylation states under the control of highly 
specific methyl transferases or demethylases.  These methylation states serve to turn on specific 
protein-protein interactions with partners that specifically recognize the methylated side chain.  
Recognition and affinity is mainly derived from cation-π interactions between the positively 
charged cationic side chain and the electron rich π surfaces of nearby aromatic rings.  This 
interaction can be quantified by incorporation of fluorinated derivatives of the aromatic amino 
acids responsible for the binding of H3K9Me3 to the HP1 chromodomain.  The cation-π 
interaction between the aromatic pocket of the HP1 chromodomain and H3K9Me3 can be 
revealed by incorporation of a series of fluorinated amino acid analogues.  A linear correlation 
between binding affinity and the calculated magnitude of the cation-pi interaction of those 
groups indicates a cation-π interaction.  Because many reader proteins for methylated lysine have 
an aromatic cage in their binding pockets, findings from the investigation of the HP1 
chromodomain will provide broad insight into this class of proteins. 
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CHAPTER(1:(INTRODUCTION(
STRUCTURE(AND(FUNCTION(OF(G3QUADRUPLEX(DNA(AND((
METHODS(FOR(TARGETING(THE(G3QUADRUPLEX(STRUCTURE(!!
A. Significance 
The right-handed double helical structure of DNA is well known.  However, growing 
evidence has suggested that DNA can adopt a variety of alternative conformations based on 
sequence motifs and interactions with various proteins.1 One example of these alternative DNA 
structures that has gained great interest in recent years is the G-quadruplex (G4) structure.  
Interest has increased enormously due to the unique physical properties of the G-quadruplex 
structure as well as the presence of guanine (G)-rich sequences in biologically functional regions 
of many genomes.2 For example, G-rich regions with the potential to form G-quadruplex 
structures are found in telomeres, double stranded break (DSB) sites, and transcriptional start 
sites (TSS). In addition to the important regulatory and structural functions of the G4 structure, it 
could also be a source of genomic instability leading to cancer, aging and human genetic 
diseases.  Given the propensity of G-quadruplex structures to control many biological functions, 
it has become desirable to identify small molecules that can bind to and stabilize G-
quadruplexes.3 Moreover, despite the fact that G4 DNA has been studied rigorously in vitro, 
further studies are necessary to determine if this structure forms in vivo and what exactly its 
cellular roles might be.  Small molecules that target the quadruplex structure could be useful in 
further probing the biological function and significance of quadruplex structures in vivo. 
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B. G-Quadruplex Structure 
 G-rich sequences of nucleic acids can form four-stranded, helical DNA or RNA 
structures comprised of 4 guanine bases brought together in a square planar arrangement 
connected by Hoogsten hydrogen bonds (Fig. 1.1a).5,6 The G-rich core typically consists of two 
or more G-tetrads stacked via π-π interactions with intervening sequences extruded as single-
stranded loops (Fig. 1.1b).  The sequence and size of the loop regions can vary, with the loops 
usually containing 1-7 nucleotides.  The stacks are joined together by the normal sugar-
phosphate backbone with the structure further stabilized by monovalent cations, typically 
potassium (K+) or sodium (Na+), that occupy the central cavity neutralizing the electrostatic 
repulsion of the guanine oxygens (Fig. 1.1a).7,8   
 
Figure 1.1 The G-quadruplex structure (a) An illustration of the G-quadruplex G-quartet.  The 
quartet is pictured as a square in the other panels of the figure.  M+ denotes a monovalent cation. 
(b) Schematic of intramolecular (left) and intermolecular (right) G-quadruplex DNA structures.  
The arrows indicate the direction of the DNA strands.4 
 
The quadruplex structure can be extremely stable.  However, the stability can vary due to 
differences in length and sequence of the loop, strand orientation and alignment and the nature of 
the binding cations. G-quadruplex structures can be parallel, antiparallel or hybrids of the two 
and can be made up of one (intramolecular), two or four separate strands (intermolecular) (Fig. 
1.1b).6 Loops may link positions on the top (or bottom) of the stacks, forming diagonal (Fig. 
Intramolecular G4 Intermolecular G4 a b 
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1.2c) or lateral loops (Fig. 1.2b) depending on which guanines are linked.  Additionally, loops 
can link a guanine on the top G-tetrad to a guanine on the bottom providing a double-chain 
reversal loop (Fig. 1.2a).9-12 Consequently, the G4 motif can adopt a great variety of different 
topologies with different combinations of strand polarities and loop types.  In addition to 
differences in the length and sequences of the loop, the structure of the quadruplex can vary 
greatly due to differences in groove size based on relative strand orientation.  All quadruplexes 
have four grooves, defined as the cavities bounded by the phosphodiester backbone.  Parallel 
quadruplexes have all guanine glycosidic angles in an anti conformation while anti-parallel 
quadruplexes contain both syn and anti guanines arranged in a way that is particular for a given 
topology and set of strand orientations.6 Furthermore, the formation and stability of the G-
quadruplex is monovalent cation-dependent.  A strong negative electrostatic potential is created 
by the guanine O6 oxygen atoms which form a central channel of the G-tetrad stack where the 
cations are located (Fig. 1.1a). The precise location of the cation between the tetrads is dependent 
on the nature of the cation.  Potassium (K+) and sodium (Na+) are the most prevalent cations, 
with the smaller Na+ cation orienting itself in the plane of the G-tetrad while the larger K+ ion lies 
equidistant between each tetrad plane.  Studies have shown that the change from Na+ to K+ can 
induce profound structural changes.13,14  
! 4!
 
Figure 1.2 Structures of the human unimolecular telomeric quadruplex formed by the sequence 
d[AGGG(TTAGGG)3].6 In each case two views are shown with arrows depicting strand 
polarities. (a) The Na+ form, determined by NMR containing two anti-parallel and two parallel 
strands with a diagonal and two lateral loops.  (b) K+ form A, determined by crystallography 
containing all parallel strands with three strand reversal loops resulting in four equal grooves (c) 
K+ form B, showing the topology determined by NMR, containing three parallel strands with one 
oriented anti-parallel. 
 
 
 It has been predicted that intramolecular quadruplex structures can form at specific G-
rich regions in vivo.  These G-rich regions share a common sequence motif of at least four 
guanines, with each G-tract containing most often at least three guanines.  Computational 
analyses have revealed that there are >375,000 G4 motifs in the human genome including those 
in ribosomal and telomeric DNA.  However, it is still unclear how many of these motifs can form 
stable G-quadruplex structures in vivo and, if they do, when they form.15-18   
 
 
 
a 
b 
c 
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C.  Biological Relevance 
 Computational studies have revealed that G4 motifs are not randomly located within the 
genome, but tend to cluster in particular genome regions such as promoters.    Due to the 
nonrandom location and evolutionary conservation of the position of G4 motifs within the 
genome, it is suggested that the G-quadruplex structure plays one or more positive functions 
within the cell.19,20 Telomeres are regions of the chromosome that contain a high concentration of 
G4 motifs due to their high GC content and the single-stranded nature of the telomeric overhang.  
G4 DNA motifs are also common G-rich regions up- and downstream of TSSs and near 
transcription factor binding sites.  
i.  G4 Structures at telomeres 
 Telomeres make up a nucleoprotein complex at the ends of linear chromosomes that 
protect chromosomes from degradation, end-to-end fusions, and being recognized as DSBs.21 
They contain a double-stranded region and a single-stranded G-rich 3’ overhang (Fig. 1.3).  In 
most telomeric DNAs, guanines and cytosines are distributed asymmetrically between two DNA 
strands with the G-rich strand being longer than its complement, resulting in single-stranded ‘G-
tails’ at the termini of the chromosome.  Despite differences in the exact sequence, the G-rich 
strand of various telomeric sequences can usually form stable G4 structures in vitro.22-24 
 Due to the biochemical properties of DNA polymerases, they cannot replicate the very 
ends of linear chromosomes.  Therefore, as a healthy cell undergoes replication, there is a 
progressive shortening of the telomeric region following each cell division.  Normal cells have a 
limited replicative lifespan and once a critical shortening of the telomere is reached, the cell is 
signaled for growth arrest or apoptosis.  However, a reverse transcriptase enzyme, telomerase, 
can be activated to lengthen the G-strand of the telomeric region (Fig. 1.3).  Human telomerase is 
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inactive in most somatic cells but is found to be upregulated in many cancers where it is thought 
to promote the lifespan of malignant cells.25 The G-quadruplex structure can inhibit the activity 
of telomerase by preventing the enzyme from annealing to G-strand overhangs.26,27 Because 
telomerase is active in a large number of human cancers and can be influenced by the formation 
of the G-quadruplex structure, there has been great effort to design a variety of small molecules 
that can bind and stabilize G4 structures (Fig. 1.3).28 
 
Figure 1.3 Schematic outlining the role of human telomerase in cancer.  Telomeric sequences 
can fold into G-quadruplex structure inhibiting the activity of the reverse transcriptase 
telomerase. Due to the ability of the G4 motif to inhibit the enzyme telomerase, it has become 
desirable to design small molecules that can bind to and stabilize the quadruplex structure for use 
as novel anticancer therapies.   
 
 
ii.  Effects of G4 structures on DNA transcriptional regulation 
 In addition to their presence in telomeres, a high concentration of G4 motifs have been 
found in the promoter regions of genes suggesting that G4 structures play a potential role in the 
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regulation of gene transcription.  Bioinformatics has shown that the promoter region of human 
oncogenes and regulatory genes (i.e. transcription factors) are more likely than the average gene 
to contain G4 motifs.29 There is an equilibrium between two forms of the DNA during 
transcription.  One side of the equilibrium is the double helix DNA, while on the other side one 
strand is separated and has folded up into a G-quadruplex.30 As a result, studies have suggested 
that the presence of some G4 structures during DNA replication could influence transcription in 
positive and negative ways.  Depending on which DNA strand contains the G4 motif, the 
structure could inhibit transcription (if the motif is on the template strand) or enhance 
transcription (if the motif is on the non-template strand) (Fig. 1.4a and 1.4b).  Also, proteins that 
bind to the G4 structures may also affect transcription (Fig. 1.4c and 1.4d). 31-33 A number of 
oncogenes have been found to contain the G4 motifs in their promoter region leading to the 
possibility of novel therapeutics that target the quadruplex structure.  The addition of a G-
quadruplex ligand will energetically favor the G4 structure, thus providing a way to manipulate 
or control transcription of a particular gene.  
 
 
! 8!
 
Figure 1.4 Proposed functional roles of G-quadruplex structures during transcription.4 (a) G4 
structures are thought to block transcription by inhibiting polymerase (blue). (b) G4 structures 
are postulated to facilitate transcription by keeping the transcribed strand in the single-stranded 
conformation.  (c) G4 structure may stimulate transcription by recruiting proteins (green) that 
recruit or stimulate polymerase (d) G4 structures are suggested to block transcription by 
recruiting G4 binding proteins (orange) that can directly or indirectly repress transcription 
(purple).  
 
 
D.  Methods for Determination of Quadruplex Topology and Structure  
i.  CD Spectroscopy 
 A number of quadruplex studies have used biophysical chemistry, mainly circular 
dichroism (CD) to assign topology.  CD is sensitive to stereochemical variations, allowing it to 
be an important technique for studying subtle conformational changes and supramolecular 
interactions.34 Using CD spectroscopy it is possible to discriminate between quadruplex 
topologies having differences in parallel and anti-parallel strand orientation due to different 
arrangements of anti/syn glycosidic angles.  Therefore, CD is a useful and rapid method for 
establishing an overall fold pattern as it requires little sample and is suited to examining a wide 
range of solution conditions and their influence on quadruplex formation.  Classic parallel and 
5’#
3’# 5’#
3’#
5’#
3’# 5’#
3’#
c Stimulation of transcription 
d Transcription blocking (recruitment of repressors) 
5’#
3’# 5’#
3’#
a Polymerase stalling, inhibition of transcription 
5’#
3’# 5’#
3’#
b Facilitating transcription 
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anti-parallel quadruplexes provide similar traces but with maxima at distinct wavelengths.  For 
quadruplexes assigned to be parallel-stranded, a maximum is present at ~260 nm and a minimum 
at ~240 nm while the maximum and minimum for an anti-parallel quadruplex are typically at 
around 290 and 260 nm, respectively.35-37 CD has predominantly been used to study telomeric 
sequences and those with regular repeating loop regions.  More complex quadruplex-forming 
show decreased reliability when assigning topology since they may not conform to observed 
telomeric quadruplexes, multiple species cannot be identified by CD and non-telomeric loop 
sequences may perturb the CD spectra in unforeseen ways.6,38  
ii.  X-ray Crystallography and NMR Spectroscopy 
 X-ray crystallography and high-field NMR spectroscopy are other ways to determine 
topological assignment as well as a more detailed atomic-level structure determination.39 
However, there can be limitations to each of these methods.  In order to successfully determine a 
structure by NMR, the sequence needs to form a kinetically stable species in solution while the 
presence of multiple species limits the structural information that can be obtained.  It is common 
to set up a screen of mutated sequences and other variants until one is found that produces a 
well-resolved NMR spectrum showing a single species amenable to analysis.40 Similarly, 
crystallography uses site mutations and/or sequence screening to find sequences that will 
crystallize.6 The various structures formed in solution as variants of the human telomeric two-
repeat sequence show that such mutations and changes cannot always reliably preserve a 
particular topology and will inevitably alter the equilibrium between different structures.41 
Therefore, generalizations from any one NMR or crystal structure needs to be done carefully and 
need to acknowledge the contribution of modified/additional nucleotides.   
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E.  G-Quadruplex Ligands 
 The G-quadruplex structure has been implicated in several biological dysfunctions that 
selectively alter the integrity of cancer cells.  As a result, G-quadruplex binders that stabilize the 
G4 structure promise to lead to the discovery of novel anticancer agents.  A common binding 
motif for a ligand is a flat aromatic molecule that binds to the G-quartet of the external face of 
the quadruplex resulting in stabilization of the structure through π-π stacking and electrostatic 
interactions (Figure 1.5b).  The G-quartet has a large flat surface therefore an efficient 
quadruplex ligand should feature a large aromatic surface, much larger than that of a duplex 
binder, improving the aromatic-aromatic overlap and providing selectivity over duplex 
DNA.6,41,42 Electrostatic interactions between positively charged sidechains of the ligands and 
the negatively charged phosphate backbone of the G-quadruplex DNA scaffold also contribute to 
stabilization of the G4 structure (Figure 1.5b).  Generally, the ligands that have been synthesized 
to date can be classified into four different categories based on their cationic nature, i.e. cationic 
(1) upon in situ protonation of an amine appendage, (2) via N-methylation of an aza-aromatic 
moiety, (3) presence of a metal center, or (4) non-cationic ligands (Figure 1.6).43  
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Figure 1.5 Despite differences in the many ligands developed that successfully target G-
quadruplex DNA over duplex DNA, G4 ligands tend to have two common features including a 
large flat aromatic surface for π stacking with the G-tetrad and protonable side chains for 
electrostatic interaction with the quadruplex grooves.  (a) Shown is an acridine ligand that targets 
G-quadruplex DNA over duplex DNA and displays the two common characteristics of G4 
ligands.  The acridine core provides a large flat aromatic surface for binding while the protonable 
pyrrolidine side chains provide positive electrostatic interactions.  (b) X-ray structure of the 
acridine ligand (red) complexed with a G4 structure (quartet=blue, backbone=grey, 
loops=orange) illustrating how the ligands can end stack with the G-tetrads of the quadruplex 
structure.43   
 
 
The usual way to target G-quadruplex DNA is the introduction of protonable sidearms 
around an aromatic core.  Neidle, Hurley and co-workers followed this method with the 
development of a bisamidoanthraquinone G-quadruplex ligand and telomerase inhibitor.44 While 
this class of molecule was shown to have telomerase inhibition activity, these molecules had 
insufficient selectivity for G4 DNA over duplex DNA for further biological studies.  To improve 
the selectivity for quadruplex DNA, Neidle and coworkers progressively modified the core and 
sidearms from anthraquinone to fluorenone, then acridone and acridine.45,46 A member of the 
3,6-disubstituted acridine series showed particular promise against G-quadruplex DNA (Figure 
1.5a).47 This structure displayed hydrophobic-π-stacking interactions between the flat aromatic 
core of the acridine and the square planar guanine residues of the G-tetrad in addition to 
electrostatic interactions between the two protonable sidechains of the ligand and the quadruplex 
grooves.  Neidle and coworkers further optimized this class of molecules by designing BRACO-
19, a molecule able to interact simultaneously with three G-quadruplex grooves due to the 
N N
H
O
N
H
O
N N
X-ray structure of the complex of disubstituted aminoalkylamido 
acridine (in red) bound to d(G4T4G4) G-quadruplex 
a b 
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addition of a third side arm.48 The optimized BRACO-19 displayed high levels of quadruplex 
stabilization as determined by FRET (fluorescence resonance energy transfer)-melting assay and 
by SPR (surface plasmon resonance) method that revealed 31-fold selectivity for the quadruplex 
structure.   Additionally, BRACO-19 shows a strong potency for telomerase inhibition as well as 
inhibition of cancer cell proliferation however, pharmacological use of this molecule has been 
limited by poor membrane permeability or cellular uptake.49 Despite these limitations, the simple 
acridine motif appears to be very valuable for G-quadruplex recognition and one that we have 
incorporated into our system design.   
 
 
Figure 1.6 Molecules exemplifying the four broad categories of G-quadruplex binding ligands. 
 
 
 Despite the number of ligands designed that successfully target G-quadruplex DNA over 
duplex by targeting the common G-tetrad of the G4 motif, a major challenge still remains to 
design ligands with specificity for individual quadruplex structures given the wide variety of 
topologies specific quadruplex sequences can adopt.  It may be possible to obtain selectivity by 
targeting the loops that vary in length and sequence as well as the grooves, which can vary in 
size due to difference in relative strand orientation.  A common strategy that has been employed 
to achieve greater high selectivity and specificity is conjugation, using a ligand that can target the 
planar surface of the G-tetrad and appending it to a variable substituent that can contact the loops 
and grooves of the quadruplex structure.   
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An initial example comes from Pedroso et al., where a library of acridine-oligonucleotide 
conjugates were synthesized and studies were carried out to examine their interaction with DNA 
quadruplexes.50 The acridine ligand was expected to exhibit selectivity for quadruplex DNA over 
duplex while the oligonucleotide attached was complementary to the G-rich telomere strand.  
These studies showed that the acridine-oligonucleotides did stabilize the telomeric quadruplex 
structure as determined by thermal denaturation experiments; however, no other sequences were 
screened against the library to determine selectivity.   
Arya et al. published a more recent example of a novel perylene-neomycin conjugate that 
was shown to bind preferentially to telomeric G-quadruplex DNA in the presence of other 
nucleic acids, including DNA, RNA, DNA-RNA hybrids, and other higher order structures 
(single strands, duplexes, triplexes, other G-quadruplexes, and the i-motif).51 The perylene 
moiety is known to end stack with the G-tetrads of the quadruplex structure, while recent studies 
have shown that neomycin can bind in the wide groove of G4 DNA.  Arya et al. showed through 
fluorescence intercalator displacement (FID) assays that the conjugated species displayed tighter 
binding than each of the parent constituents.   
In a final example, Neidle et al. published studies performed with a common G-tetrad 
interacting acridine core conjugated to various tetrapeptide substituents that have the ability to 
discriminate between different quadruplex types.52 Based on the substitution patterns selectivity 
could be seen for the parallel quadruplex derived from the human N-ras gene over the human 
telomeric quadruplex while the peptide substituent KRSR proved to show marginal superior 
selectivity and affinity over FRHR While linear peptides provided modest binding selectivity, we 
felt we could further develop this method by using cyclic peptides to deliver selectivity.  
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F.  Methods to Investigate G-Quadruplex/Ligand Interactions 
 A variety of techniques have been employed to study the interaction of natural or 
synthetic compounds with G-quadruplex structures.  These methods can vary from evaluating 
properties like ligand affinity, to more sophisticated methods used for determining kinetic, 
thermodynamic, stoichiometric and conformational data for structure-activity relationship 
studies.  Methods being used to investigate these interactions should be able to detect and 
measure the ligand selectivity for quadruplexes over duplexes or other secondary structures.  
Each method has its own advantages and disadvantages therefore more than one method is 
usually necessary to obtain complete information about quadruplex DNA/ligand interactions.  
i. Melting Temperature Measurements 
Melting temperatures can be measured, providing information about the stabilization (or 
destabilization) of the quadruplex structure by the ligand under investigation.  Quadruplex 
nucleic acids show a strong absorbance around 295 nm, which is greatly reduced in unstructured 
DNA due to the π-stacking of nucleobases in folded quadruplex structures (Figure 1.7).53 There 
is a decrease in absorbance at 295 nm upon denaturation by heating.  This simple thermal 
melting experiment is performed to demonstrate the stabilization or destabilization of a 
quadruplex structure by a ligand.  Preparation of the sample is straightforward and reasonably 
low amounts are required.  
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Figure 1.7 Schematic representation of melting temperature experiments using CD at 295 nm.53 
 
ii. CD Spectroscopy 
Circular dichroism (CD) spectroscopy is extremely useful in studying the conformation 
of nucleic acids.  As discussed previously, CD is a widely used technique to study the G-
quadruplex conformation in which the CD signal is influenced by stacking interactions between 
adjacent quartets.54 The titration of G4-ligands to quadruplexes can induce changes in the CD 
spectrum, correlating to the properties of the ligand under investigation. 
iii. Surface Plasmon Resonance  
Surface Plasmon Resonance (SPR) has become a popular method to study the kinetic and 
thermodynamic parameters of intermolecular interactions.  SPR is an optical technique that 
utilizes the decrease in intensity of a circular polarized light reflected from the surface of a glass 
prism coated with a thing metal film.  The minima in reflected light density occur at a specific 
angle at which surface plasmons of the metal are excited.  The angle at which the resonance 
occurs becomes the function of refractive index of the medium in the vicinity of the surface.  The 
variation of value at this angle is recorded, detecting any interactions involving free species in 
solution (ligand) and one that is covalently bound to the surface (DNA).  A variety of quadruplex 
forming oligonucleotides have been immobilized to sensor chips to study binding interactions 
with small organic molecules and proteins.53  
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G.  Purpose of this work 
 Given the important regulatory and structural functions of the G4 motif, we aim to 
develop quadruplex ligands that exhibit selectively over not only duplex DNA but also over 
various quadruplex sequences. In the effort to discover molecules that can discriminate against 
assorted quadruplex structures via groove recognition, we have screened libraries of cyclic 
peptide-acridine using dynamic combinatorial chemistry (DCC).  We chose to focus on cyclic 
peptides due to their prevalence in nature and their promise as biologically relevant molecules.  
Additionally, the use of cyclic peptides to target the quadruplex structure seemed promising due 
to the ability of the macrocyclic, natural product telomestatin to bind G-quadruplex DNA.  
Furthermore, in order to screen libraries of cyclic peptides in a high-throughput format, a method 
has been developed in our lab using thiol-thioester exchange in DCC.  Using this method, we can 
generate libraries of cyclic peptides from simple linear peptide building blocks in solution, 
within hours, and at a neutral pH.  These libraries can efficiently be screened against different 
quadruplex sequences as well as duplex DNA in the effort to determine the selectivity of each 
species.  Once a hit has been discovered, the molecule can easily be resynthesized as a more 
stable analogue for use in biological studies.   
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CHAPTER 2: DESIGN OF DYNAMIC COMBINATORIAL  
LIBRARIES AND EXPERIMENTS 
 
A. Background 
i. Cyclic Peptides 
Peptides are well suited to act as modulators of biological function given that all enzyme 
sites and protein-protein interactions are comprised of amino acids.1 Additionally, cyclic 
peptides can be considered naturally occurring privileged structures due to their ability to mimic 
biologically relevant regions of protein diversity, such as β-turns, which are important 
recognition elements of peptides and proteins.2,3 The constrained nature of cyclic peptides has 
been shown to enhance binding affinity by restricting conformational freedom, causing cyclic 
peptides to bind with a higher affinity to targets than their linear counterparts.5 This increase in 
binding affinity is due to the entropic advantage gained by the constrained scaffold of cyclic 
peptides.  Furthermore, cyclic peptides display a higher metabolic stability because without 
exposed termini, they are inaccessible to cellular proteases.5 The advantages offered by cyclic 
peptides are seen in nature considering many natural product antibiotics, such as tyrocidine A 
and gamidin S, are based on cyclic scaffolds.6,7 In addition, the commonly marketed drugs 
octreotide and the immunosuppressant cyclosporin A also contain cyclic peptide structures.8 
Therefore, given their high affinity, target specificity and metabolic stability, cyclic peptides 
continue to hold promise as powerful biological tools.  
Despite the promise of cyclic peptides as useful molecular tools, current methods for 
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generating libraries of structurally diverse cyclic peptides in a high-throughput format are 
limiting.  Methods for synthesizing libraries of cyclic peptides are often difficult and labor 
intensive due to the need for orthogonal deprotection strategies as well as time-consuming 
purifications at different stages of the syntheses.  Syntheses of cyclic peptides often suffer from 
low yields due to side reactions and mixtures of cyclic and linear products.5 Due to these 
complications, our lab has developed a method using dynamic combinatorial chemistry to 
generate libraries of cyclic peptides in situ in a high-throughput format.   
ii. Dynamic Combinatorial Chemistry 
Dynamic combinatorial chemistry is a method for the in situ generation of a complex 
mixture of macrocycles from smaller building blocks and is combinatorial chemistry that is 
under thermodynamic control with all library constituents under equilibrium.9 This requires that 
all library members be able to interconvert through a reversible chemical process, which can 
involve either covalent or noncovalent interactions.  The composition of the library is determined 
via the thermodynamic stability of each of the library members.  Thermodynamic control of the 
library implies that introduction of changes in conditions of the experiment will induce changes 
in the library composition.  When a template is introduced and binds to a library member, this 
species is stabilized.  The bound species is thus amplified, as the remaining building blocks will 
establish a new equilibrium increasing the concentration of the selected library member at the 
expense of the remaining library members.10-12 Therefore, in theory the amplification should be 
selective for the species that binds most tightly with the template.   
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Figure 2.1 Scheme representing dynamic combinatorial chemistry as a way to select specific 
members of a dynamic combinatorial library through noncovalent interactions by the 
introduction of a separate guest.   
 
An important feature of dynamic combinatorial chemistry is the reversible exchange 
reaction that is necessary in order for the building blocks to be capable of interconverting 
between library members.  A number of requirements are necessary for this reaction: (i) the 
reaction needs to be reversible on a reasonable timescale (ii) the reaction needs to be compatible 
with the experimental conditions including the functional groups on the building blocks and 
template, the solvent, and the pH (iii) the reaction conditions need to be mild so as not to 
interfere with the delicate noncovalent interactions involved in molecular recognition (iv) it 
needs to guarantee the solubility of all library members so as not to interfere or alter the 
equilibrium (v) it should be possible to turn off the reaction and thus kinetically “freeze” the 
selected library members enabling their isolation and characterization and (vi) ideally all library 
members should be isoenergetic to prevent production of biased libraries.5  
Three main different types of reversible reactions have been used including: noncovalent 
(hydrogen bonds), coordinative, and covalent bonds.  Our lab has focused only on covalent 
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reversible reactions therefore only reactions most relevant to the Waters lab will be discussed.  
The first example is the acid-catalyzed condensation of an amine with a ketone or aldehyde to 
form an imine.   While imine formation is reversible, imines condense and hydrolyze quickly at 
neutral to acidic pH making it an impractical exchange reaction in for biologically relevant 
templates.13 On the other hand, hydrazones can be thermodynamically stable in the presence of 
water even at lower pHs.14 The hydrazine exchange reaction is reversible and compatible with a 
wide range of solvents and functional groups.  Most applications of hydrazones in dynamic 
combinatorial chemistry involves an acyl hydrazine where the acyl group moderates the 
stabilizing influence of the amine subunit in C=N-NRR’.5 The drawback to using hydrazones as 
the exchange reaction is that exchange occurs at a pH of 4, which is not compatible with most 
biomolecules.  Another example of a covalent exchange reaction that is commonly employed in 
dynamic combinatorial chemistry is disulfide exchange, which plays an important role in biology 
due to its role in the folding of proteins and the redox state of cells.15 The mechanism includes 
the nucleophilic displacement of a thiolate anion from the disulfide through attack by another 
thiolate anion.16 This process requires deprotonation of the thiol therefore the exchange is highly 
pH dependent and allows the process to be halted by lowering the pH.  Disulfide exchange can 
be carried out at near neutral conditions (pH 7-9) making it compatible with most biomolecules.  
However, when a hit has been identified, the disulfide bond is not stable within the cellular 
environment and there is no straightforward synthetic replacement.  Additionally, this reaction is 
exceedingly slow, taking days to weeks to reach equilibrium. 
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Figure 2.2 Reversible covalent reactions used for dynamic combinatorial chemistry.  (a) Acid-
catalyzed exchange reaction between an amine and an aldehyde to form an imine.  (b) Reaction 
of a hydrazine and aldehyde to form a hydrazone.  (c) Disulfide exchange, which occurs between 
a thiolate and a disulfide bond to release a free thiolate anion.   
 
iii. Dynamic Cyclic Peptide Libraries from Thiol-Thioester Exchange 
Our lab has recently published a method utilizing thiol-thioester exchange as a reversible 
reaction for DCC to form cyclic peptides.17 The advantage of using thiol-thioester exchange over 
other exchange reactions is that it is rapid in aqueous solution at neutral pH and provides a 
native-like linkage that is successively replaceable by a more robust amide or ester 
functionality.18,19 Equilibrium is reached within 1 to 2 hours depending on the sequence, with no 
significant hydrolysis of monomers during that time.  Previous reports of the use of thioester 
exchange in DCC experiments has involved thioesters that were unsubstituted at the α-position, 
limiting the diversity of structures possible in a library of cyclic peptides.19,20 Our lab performed 
systematic studies to determine the reactivity of peptide thiol-thioester exchange to its scope and 
limitation in its application in DCC.   
Each monomer was a four-residue peptide containing a thioester at the C-terminus and a 
thiol at AA2 (Cys).  The structures of each monomer were varied at AA1, AA3 and AA4.  The 
monomers were designed so that AA2-AA3-AA4 form the macrocycle while AA1 remained 
exocyclic.  Charged amino acids were incorporated to improve water solubility and prevent 
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aggregation.  Proline was initially included in AA3 as a turn residue to favor macrocycles.  
Various amino acids were incorporated into AA4 to study their effect on the rate of 
macrocyclization, including positively charged amino acids (Lys, Arg), a negatively charged 
amino acid (Glu), and a hydrogen-bonding and neutral amino acid (Gln), and hydrophobic and 
sterically bulky amino acids (Phe, Val).   
Upon dissolution of the monomers in potassium phosphate butter (pH 7), the monomers 
underwent facile thiol-thioester exchange to form a mixture of macrocycles, with the dimeric 20-
atom macrocyclic hexapeptides as the major product.  The reaction mixture was monitored over 
time by HPLC, allowing a simple two-step mechanism to be proposed.  First, two monomers 
react to form an oligodimer followed by a ring closure intramolecular trans thioesterification 
reaction.  The oligodimer intermediate was not observed to accumulate, indicating that the 
intermolecular step is rate limiting.   
Thiol-thioester exchange can tolerate a variety of amino acids and structure-function 
studies indicated that the rate of macrocycle formation is dependent on the amino acid sequence.  
The observed reactivity of monomers with variation at the C-terminus corresponded to 
differences in sterics, with the incorporation of β-branched amino acids such as Val resulting in 
measurable hydrolysis before cyclization was complete.  When Glu was placed at the C-
terminus, it reacted more slowly than its Gln counterpart and can isomerize through anhydride 
intermediates.  Additionally, the effect of positively charged amino acids (Lys and Arg) at 
positions AA1 and AA4 were investigated were found to react significantly faster than their 
negatively charged analogues suggesting that positively charged amino acids could stabilize the 
buildup of negative charge in the transition state.  Finally, Trp was placed at the turn residue to 
determine if Pro is necessary for rapid cyclization and it was found that the Trp substituted 
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monomer actually reacted faster than the hydroxyproline (Hyp) analogue.  Stereochemistry also 
played a role in the rate of macrocyclization as D-Pro reacted considerably faster than Hyp 
suggesting that chirality has an influence on the accessibility of the thioester or thiol.   
 
Figure 2.3 Scheme depicting macrocyclization of peptides via thiol-thioester exchange. (a) 
General design of monomers and major products (b) Sequence of steps toward dimeric cyclic 
thiodepsipeptide. 
 
 
 In summary, our lab has developed an efficient method to rapidly generate libraries of 
macrocyclic thiodepsipeptides at netrual pH for high-throughput screening.  Upon mixing two or 
more monomers, we can form a complex library of cyclic thiodepsipeptides generated in situ 
under thermodynamic control.  These libraries can then be screened against a particular target 
efficiently within hours.  Given the transient stability of thioesters in vivo, a “hit” in the high-
throughput screening can be resynthesized as a more stable analogue by replacing the thioester 
group with an amide or ester.  Our lab then looked to apply this method of high-throughput 
screening to find cyclic peptides binders for G-quadruplex DNA.   
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B. System Design  
i.  Dynamic Combinatorial Library 
Our strategy for the discovery of high-affinity ligands with selectivity between 
quadruplexes uses a common acridine core to target the planar surface of the G-tetrad, appended 
with variable peptide substituents to contact the loops and grooves that distinguish each 
quadruplex structure.  We chose the acridine ligand due to the high selectivity it provides for 
quadruplex DNA over duplex DNA.  Previously, Neidle and coworkers screened a number of 
linear peptide-acridine ligands in the effort to gain selectivity amongst individual quadruplex 
structures.  While linear peptides provided modest binding selectivity in Neidle’s work, we felt 
that cyclic peptides could deliver greater selectivity and potentially fit nicely into the grooves of 
the quadruplex structure. Using methods previously developed in our lab, we wanted to create 
libraries of cyclic peptides using thiol-thioester exchange in dynamic combinatorial chemistry. 
The dynamic combinatorial libraries consisted of tetrapeptides appended to an acridine core to 
target the quadruplex structure with the tetrapeptides designed to undergo thiol-thioester 
exchange by incorporation of a Cys at AA2 and a thioester at the C-terminus. Since the loops and 
peripheral grooves of the quadruplex structure provide a pattern of hydrogen bonding, 
hydrophobic π-surfaces, and negative charges unique to a particular quadruplex sequence, we 
chose to focus on the incorporation of amino acids with hydrogen bonding groups, positive 
charges or aromaticity to facilitate favorable interaction. 
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Figure 2.4 General design of monomer library with acridine ligand incorporated at the N-
terminus to target the G-tetrad of the quadruplex structure. Cysteine is incorporated at AA2 along 
with a thioester installed at the C-terminus to facilitate thiol-thioester exchange, while a Pro was 
included at the AA3 as a turn residue to aid in cyclization.  
 
ii. Biological Targets 
The goal of this project is to find molecules that can bind to, and differentiate between 
various G-quadruplex structures.   With this in mind, it was necessary to choose different DNA 
sequences to screen our libraries against.  The first sequence we chose was the human telomeric 
(Htelo) sequence given the extensive studies that have been carried out surrounding the role of 
quadruplex formation in the single-stranded telomeric region and its role in the inhibition of the 
reverse-transcriptase enzyme telomerase. Secondly, we chose three oncogenes whose promoter 
regions are known to contain G-quadruplex folding patterns and structures, cKit21, cMyc22 and 
NRas.  Finally, we chose a dsDNA sequence containing guanines as a control to determine the 
selectivity of our library for quadruplex DNA versus duplex.  
The first oncogene we chose to screen is the c-myc oncogene, which is one of the most 
commonly malfunctioning genes in human cancers.22 The myc family of oncogenes encodes 
phospho-proteins that activate genes and encourage forward cell growth.  Normally, the human 
c-myc gene is tightly regulated and it is the overexpression of this gene that leads to the 
progression of many cancers.  The c-myc gene utilizes four promoters with the nuclease-
hypersentive element III1 accounting for 75-85% of total c-myc transcription.23 It is this region of 
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the c-myc promoter region that can form G-quadruplexes under physiological conditions thereby 
playing an important role in the transcriptional regulation of this oncogene.   
The promoter region of c-kit is the second sequence we chose to screen against.  c-kit is 
an oncogene which codes for a tyrosine kinase receptor and is pivotal for relaying extracellular 
signals.  When activated, KIT stimulates proliferation, differentiation, migration and survival.24 
Overexpression of the c-kit gene results in uncontrolled cell proliferation and is considered the 
primary pathogenic event in gastrointestinal stromal tumors.  A quadruplex forming 21-
nucleotide sequence upstream of the transcription initiation site has been identified on the G-rich 
strand, which occupies a site required for core promoter activity.25 Until recently, all cancer 
therapies targeting kinases inhibit the kinase protein after expression rather than controlling its 
expression.  The position of the quadruplex sequence in the promoter region of c-kit makes it an 
attractive target for the regulation of c-kit at the transcriptional level.   
A final oncogene that we chose to focus on is the NRAS gene that is another of the most 
frequently mutated oncogenes detected in human cancer.  The NRAS gene encodes for a guanine 
nucleotide (GTP/GDP)-binding protein that acts as a signal transducer.  Mutated forms of the 
gene can result in a protein locked activated state, transmitting constitutively signals for cell 
proliferation to the nucleus.  The promoter of the NRAS gene contains a nuclease hypersensitive 
polypurine-polypyrimidine element (NHPPE) that is essential for transcription and has the ability 
to form the G-quadruplex structure.26 Studies have again shown that formation of G4 DNA in the 
control region of the gene may contribute to the regulation of expression of the NRAS gene.  Due 
to its role in the pathogenesis of cancer, the quadruplex structure of the NRAS gene is an ideal 
target for anticancer drugs.   
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C. Conclusions  
The goal of this project is to identify small molecules that can bind to and stabilize the G-
quadruplex structure of DNA.  Previous studies have shown modest success in differentiating the 
various possible quadruplex structures and topologies through the use of acridine-linear peptides 
conjugates.  We felt strongly that the use of cyclic peptides could deliver greatly improved 
selectivity while also providing the added advantages of mimicking native protein structure, 
displaying enhanced metabolic stability and possessing structural preorganization thus reducing 
the entropic cost of binding.  Despite the therapeutic potential of cyclic peptides, the options for 
synthesizing structurally diverse libraries in a high-throughput format are limiting.  Using a 
strategy that has been developed in our lab, we propose screening libraries of solution-phase 
cyclic peptides generated using thiol-thioester exchange for DCC.  Our system has been designed 
as tetrapeptides containing a thioester installed at the C-terminus with the acridine ligand 
attached at the N-terminus.  We selected the four quadruplex forming sequences of Htelo, c-kit, 
c-myc and NRAS as our biological targets due to their biological importance and implications in a 
number of different cancers.  The next step was to synthesis the monomers of our library 
followed by optimization of the dynamic combinatorial experiments.   
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CHAPTER 3: SYNTHESIS OF MONOMERS FOR  
DYNAMIC COMBINATORIAL LIBRARIES 
 
A. Monomer Synthesis 
i. Synthesis of acridine ligand 
The monomer system design consisted of a tetrapeptide containing a cysteine residue and 
thioester installed at the C-terminus to facilitate thiol-thioester exchange.  Additionally, an 
acridine ligand was installed at the N-terminus to target the quadruplex structure (Figure 3.1).  
The tetrapeptide is synthesized using solid phase peptide synthesis followed by coupling of the 
free N-terminus to the acridine ligand.  Given the excellent selectivity of the acridine motif for 
the quadruplex structure over the duplex DNA, the synthesis of BRACO-19 (1) is well 
precedented.1,2 However, the structure synthesized was slightly modified as shown in structure 2 
to include a carboxylic acid group off of the phenyl side chain allowing for coupling to the N-
terminus of the peptide substituents.   
 
Figure 3.1 Structure of the G-quadruplex ligand BRACO-19 (1) and the modifications made to 
the acridine ligand (2) to allow incorporation via solid phase synthesis at the N-terminus of the 
tetrapeptide monomers.  
 
The synthesis of the acridine ligand began with the nitration of diphenyl methane 
followed by oxidation to the ketone (2) using chromium oxide.  The nitro groups were reduced in 
N
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the presence of tin (II) dichloride in refluxing hydrochloric acid to provide the cyclized 3,6-
diaminoacridone product (3).  This step was problematic, as it was difficult to remove the tin 
from the final product.  This problem was circumvented by first dissolving the product in water 
after filtration from hydrochloric acid, followed by basification using 2N NaOH, converting the 
tin byproduct to a water soluble compound.  After addition of the base, the mixture was heated to 
reflux for 15 minutes to ensure removal of the tin byproduct.  Compound 4 was then acylated by 
treatment with 3-chloropropionyl chloride followed by subsequent amination with pyrrolidine 
providing compound 8. 
 
Figure 3.2 Synthesis of the acridine ligand (2).  Conditions: (a) HNO3 (10 equiv) at 0°C in 
H2SO4, warm to rt over 4 hours (88%) (b) CrO3 (4 equiv) in AcOH, reflux, 10 hours (quant.) (c) 
SnCl2 in conc. HCl (0.3M) and EtOH (0.67M), reflux, 8 hours (49%) (d) 3-chloropropionyl 
chloride (20 equiv), 80°C, 10 hours (77%) (e) Pyrrolidine (20 equiv), reflux, 10 hours (87%) (f) 
POCl3, 100°C, 3 hours (g) 4-aminobenzoic acid, EtOH, reflux, 12 hours (40% over two steps). 
 
The next steps of the synthesis introduced some complications.  Following literature 
procedure, the acridone compound 8 was heated to 100°C in phosphorous oxychloride.  After one 
hour, the reaction was cooled and diethyl ether was added.  The precipitated product was filtered 
and then added to a mixture of ice-aqueous ammonia-chloroform in an ice bath.  Further aqueous 
ammonia was added to ensure that the mixture remained alkaline and the chloroform layer was 
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separated. When following this literature, it was found that upon filtration the product would 
form an oil rather than the reported solid, most likely due to hydrolysis of the 9-chloroacridine 
product.  In order to avoid hydrolysis of the product, upon completion of the reaction diethyl 
ether was added and the reaction mixture poured into falcon tubes.  The precipitated product was 
then centrifuged and the supernatant decanted off.  The solid product was rinsed thoroughly with 
ether and centrifuged two more times.  The solid was dried in vacuo and taken forward as the salt 
to the next step.  By using centrifugation rather than filtration, the exposure of the product to the 
atmosphere was minimized thus preventing hydrolysis of the product.   
The final product was formed by dissolving 9-chloroacridine compound 9 in ethanol with 
the addition of 4-aminobenzoic acid.  Given the deviations in the previous step from literature 
procedure, it was necessary to also optimize the final reaction of the synthesis.  Since compound 
9 was carried forward as the salt, it had poor solubility in chloroform.  The compound showed 
better solubility in methanol, but the reaction was messy with a number of side products being 
formed.  Ethanol proved to be the best solvent providing the final product cleanly in 40% yield 
over two steps.  The final acridine compound 10 used without further purification in the 
synthesis of the monomers.   
ii. Synthesis of monomers 
The peptide portion of the monomers was synthesized via traditional solid phase peptide 
synthesis (SPPS).  The synthesis began by pre-loading the first amino acid onto 2-chlorotrityl 
chloride resin, which provides a carboxylic acid at the C-terminus upon cleavage (Figure 3.3).  
The synthesis of the peptide then proceeded as usual with Fmoc deprotection in 20% piperidine 
and coupling of subsequent amino acids using the activators HBTU/HOBt.  After synthesis of 
the peptide portion of the monomer, the N-terminus was either acetyl capped (Figure 3.4) or the 
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acridine ligand was coupled (Figure 3.5) in the presence of PyBOP, DIPEA and HOBt in DMF.  
Following capping of the peptide, the protected peptide fragment was orthogonally cleaved from 
the resin using 1% TFA in dichloromethane.   
 
Figure 3.3 Fmoc solid phase synthesis of peptides on Cl-tritylchloride resin. Conditions (a) 
Fmoc-amino acid (2 equiv), DIPEA (8 equiv), CH2Cl2, 2 x 1hour (b) Standard SPPS with 3 
amino acid residues; Coupling steps: Fmoc-amino acid (4 equiv), HBTU (4 equiv), HOBt (4 
equiv), DIPEA (4 equiv), DMF, 1.5 hour; Deprotection steps: 20% piperidine, DMF, 15 minutes.  
 
 
 
 
 
Figure 3.4 Synthesis of the acetyl capped peptide monomers. Conditions: (a) Ac2O (5%), 2,6-
lutidine (6%), CH2Cl2 (b) 1% TFA, CH2Cl2, 3 x 3 minutes (c) Methylthioglycolate (4 equiv), 
PyBOP (4 equiv), DIPEA (4 equiv), 1 hour (d) TFA: water: TIPS: EDT (94:2.5:1:2.5), 4 hours. 
 
The next step in the synthesis is formation of the thioester.  As previously published in 
our lab, the thioester was synthesized by activation of the C-terminus with PyBOP and DIPEA in 
DMF in the presence of methylthioglycolate (Figure 3.4).  In the case of the acetyl-capped 
monomers, this reaction was carried out smoothly producing the desired thioester product.  
However, when the peptide was capped at the N-terminus with the acridine ligand, it was found 
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after workup that there remained a 50:50 mixture of thioester and carboxylic acid.  It was 
hypothesized that incomplete reaction of the carboxylic acid was due to poor solubility. 
Therefore, alternative coupling reagents and solvents were used, finding that DIC in CH2Cl2 led 
to complete conversion of the carboxylic acid to the thioester (Figure 3.5).  Moreover, it was 
found that the addition of the reagents was very important to prevent epimerization of the amino 
acid at the C-terminus.  Initially, activator (DIC or PyBOP) was added to the peptide in the 
presence of DIPEA to activate the carboxylic acid before addition of the methylthioglycolate.   
However, this led to two peaks of identical mass when purified by HPLC, which was believed to 
be the result of epimerization.  To correct for this, methylthioglycolate was added first to the 
reaction mixture, followed by addition of the base and finally, addition of the activator.  Upon 
formation of the thioester, the peptide was deprotected in the presence of 94:2.5:1:2.5 
trifluoroacetic acid (TFA): water: triisopropylsilane (TIPS): ethanedithiol (EDT) and purified via 
RP-HPLC. 
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Figure 3.5 Synthesis of the acridine-peptide monomers. Conditions: (a) 2 (1.2 equiv), PyBOP (4 
equiv), HOBt (4 equiv), DMF, 10 hours (b) 1% TFA, CH2Cl2, 3 x 3 minutes (c) 
Methylthioglycolate (30 equiv), DIC (20 equiv), DIPEA (20 equiv), 10 hours (d) TFA: water: 
TIPS: EDT (94:2.5:1:2.5), 4 hours. 
 
B. Experimental Section 
i. Materials and General Methods 
Solvents were of HPLC or reagent grade quality and purchased commercially from 
Sigma-Aldrich. Starting materials were purchased commercially from Fisher Scientific unless 
otherwise noted and used without further purification. 
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ii. Synthesis of acridine ligand 
Bis(2,3-dinitrophenyl)methane (4) A suspension of diphenylmethane (5 g, 29.7 mmol) 
was stirred in 150 mL of H2SO4.  The mixture was cooled to -10° C in a salt/ice bath.  12.4 mL 
of HNO3 was added slowly and the reaction mixture allowed to warm slowly to room 
temperature over a period of 4 hours.  The reaction was quenched by pouring the reaction 
mixture over ice in a 500 mL Erlenmeyer flask.  The resulting precipitate was filtered and 
washed thoroughly with water followed by multiple washes with MeOH.  (9.1 g, 26.1 mmol, 
88%).  
Bis(2,3-dinitrophenyl)methanone (5) Compound 4 (9.1 g, 26.1 mmol) was dissolved in 
250 mL of acetic acid.  Chromium(VI) oxide (10.4 g, 104.6 mmol, 4 equiv) was added carefully 
and portion wise to the reaction mixture.  The reaction was then heated to reflux overnight.  The 
reacted was stopped by cooling to room temperature and pouring onto ice in a 500 mL 
Erlenmeyer flask.  The resulting precipitate was collected by filtration and washed thoroughly 
with water.  (9.5 g, 26.1 mmol, quant.) 
3,6-diaminoacridin-9(10H)-one (6) Tin(II) chloride (26.2 g, 138.1 mmol, 10 equiv) was 
heated to reflux in concentrated hydrochloric acid (40 mL) under nitrogen for 15 minutes in a 
three neck roundbottom flask.  After 15 minutes, the mixture was allowed to cool slightly and 
compound 5 (5 g, 13.8 mmol) was added in one of the side necks, keeping the reaction under an 
inert atmosphere.  20 mL of EtOH was added to the reaction and heated to reflux overnight.  The 
reaction was then cooled to room temperature and filtered without washing.  The resulting solid 
was dissolved in water and basified using 2 N NaOH.  The mixture was heated to reflux for 10 
minutes to ensure removal of the tin byproduct.  After heating, the reaction was cooled to room 
temperature and the product isolated by filtration and washed thoroughly with water to provide 
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acridone compound 6 as a tan solid.  (1.5 g, 6.7 mmol, 49%). 
N,N’-(9-oxo-9,10-dihydroacridine-3,6-diyl)bis(3-chloropanamide) (7) Compound 6 (1.5 
g, 6.7 mmol) was suspended in 12.5 mL of 3-chloropropionyl chloride (133.2 mmol, 20 equiv).  
The reaction was heated to 80°C and left to stir overnight under nitrogen.  The reaction was 
cooled to room temperature and 12.5 mL of Et2O was added and allow to stir for 15 minutes.  
The resulting precipitate was filtered and added to a solution of 1:1 Et2O and aqueous NaHCO3.  
The suspension was stirred for another 15 minutes and filtered.  The product was washed 
thoroughly with Et2O to provide a brown solid. (2.1 g, 5.2 mmol, 77%). 
N,N’-(9-oxo-9,10-dihydroacridine-3,6-diyl)bis(3-(pyrrolidine-1-yl)propanamide) (8) 
Compound 7 (2.1 g, 5.2 mmol) was heated to reflux in pyrrolidine (10 mL, 104.0 mmol, 20 
equiv) and left to stir overnight under nitrogen.  The reaction was cooled to room temperature 
and aqueous NaHCO3 (10 mL) was added and the mixture was allowed to stir for 1 hour.  The 
resulting precipitate was filtered and washed thoroughly with Et2O. (1.8 g, 3.8 mmol, 73%).  
N,N’-(9-chloroacridine-3,6-diyl)bis(3-pyrrolidin-1-yl)propanamide (9) Compound 8 (1.8 
g, 3.8 mmol) was suspended in 40 mL of POCl3 and stirred at 100° C under nitrogen for three 
hours.  Upon completion of the reaction, the mixture was cooled to room temperature and poured 
into two falcon tubes.  Et2O (15 mL) was added to each tube causing the product to precipitate 
out of solution.  The falcon tubes were centrifuged briefly to form a pellet of the product at the 
bottom and the Et2O layer decanted off.  This was repeated two more times by adding Et2O (15 
mL) to rinse the product and centrifuged and decanted off.  The product was dried under vacuum 
before immediate use in the next reaction.  
4-((3,6-bis(3-(pyrrolidine-1-yl)propanamido)acridin-9yl)benzoic acid (2) Compound 9 
was used immediately after the previous step and was suspended in 40 mL of EtOH.  4-
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aminobenzoic acid (1.0 g, 7.6 mmol, 2 equiv) was added to the reaction mixture and refluxed 
overnight.  The EtOH was evaporated off and 0.1% TFA (50 mL) was added to the reaction 
mixture and washed three times with EtOAc to remove excess 4-aminobenzoic acid.  The 
aqueous layer was lyophilized down to provide the product as an orange powder.  (1.2 g, 2.0 
mmol, 53% over 2 steps).  
iii.  Synthesis of monomers 
9-Fluorenylmethoxycarbonyl (Fmoc) protected amino acids were purchased from 
Advanced Chemtech. HBTU and HOBt were purchased from Advanced Chemtech. PyBOP was 
purchased from Novabiochem. 2-Chlorotritylchloride resin was purchased from ChemPep.  The 
first amino acid was preloaded onto 2-chlorotrityl resin (0.1 mmol).  Resin was activated with 
1mL of thionyl chloride in 9 mL of CH2Cl2 for 1 hour in a peptide flask and bubbled with 
nitrogen.    The first amino acid was loaded onto the resin with DIPEA (8 equiv) and Fmoc-[N]-
protected amino acid (2 equiv) in CH2Cl2 for one hour, two times while being bubbled with 
nitrogen.    The remaining portion of the peptides was synthesized by automated solid-phase 
synthesis on a Thuramed Tetras peptide synthesizer (version X94) using Fmoc protected amino 
acids. Activation of amino acids was performed with HBTU and HOBT in the presence of 
DIEPA in DMF. Peptide deprotection was carried out in 2% DBU (1,8 diazabicyclo[5.4.0]undec-
7-ene) and 2% piperidine in DMF for approximately 15 min. Double coupling cycles (60 min 
each) were used for each amino acid coupling step. Peptides were capped with either Ac2O or 
compound 2 using the following procedures.  After formation of the thioester the peptide was 
globally deprotected using 95:2.5:1:2.5 trifluoroacetic acid (TFA): water: triisopropylsilane 
(TIPS): ethanedithiol (EDT) for 4 h. TFA was evaporated and cleavage products were 
precipitated with cold ether. The peptide was extracted into water and lyophilized. It was then 
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purified by reverse-phase HPLC, using a C-18 semipreparative column and a gradient of 0 to 
100% B over 50 min, where solvent A was 95:5 water:acetonitrile, 0.1% TFA and solvent B was 
95:5 acetonitrile:water, 0.1% TFA. After purification, the peptide was lyophilized to powder and 
identified with ESI-TOF mass spectroscopy.  
Acetyl capped monomers Following the above general procedure, monomers were 
manually acetylated at the N-terminus with 5% acetic anhydride and 6% lutidine in DMF for 30 
min. Cleavage of the peptide from the resin was performed in 1% TFA in dry dichloromethane at 
three times for three minutes. The filtrate was concentrated by rotary evaporation to obtain the 
cleavage product as a yellow oil. The product was dried under high vacuum and then was 
dissolved in 3.6 mL of dry DMF. To that solution was added 40 µL N,N-Diisopropylethylamine 
(DIPEA), 22 µL methyl thioglycolate, 86 mg PyBOP and the reaction was stirred under N2 at 
room temperature for 1 h. DMF was removed under high vacuum to obtain yellow oil. The 
peptide was deprotected using the above general procedure. 
Monomers capped with acridine ligand Following synthesis of the peptide on the peptide 
synthesizer, the peptide was transferred to a peptide flask and reacted with compound 2 (1.5 
equiv), PyBOP (4 equiv), HOBt (4 equiv) and DIPEA (4 equiv) in DMF while bubbling with 
nitrogen overnight.  The peptide was cleaved from the resin using 1% TFA in CH2Cl2 for three 
times at three minutes.  The thioester was formed by dissolving the peptide in CH2Cl2 (0.1 M) 
and treatment of the fully protected peptide with methylthioglycolate (30 equiv), DIC (20 equiv) 
and finally DIPEA (30 equiv).  The reaction was stirred overnight under nitrogen.  The solvent 
was removed by rotory evaporation.  Peptide was deprotected using the above general procedure.   
 !
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CHAPTER 4: DYNAMIC COMBINATORIAL EXPERIMENTS 
 
A. Background 
The molecular recognition of DNA is fundamental to many biochemical processes related 
to transcription, regulation and gene expression.  Therefore, there has been considerable interest 
in identifying small molecules that bind selectively and with strong affinity to quadruplex DNA, 
amongst other nucleic acid structures.  Dynamic combinatorial chemistry (DCC) has become an 
increasingly popular tool for understanding molecular recognition.1 While an enormous number 
of studies have demonstrated the potential of DCC to identify unexpected and novel receptor 
molecules, there have been limited studies with nucleic acids.  Additionally, studies have been 
performed to identify small molecules with affinity for duplex DNA, quadruplex DNA and RNA 
however; almost all examples have utilized the reversible thiol-disulfide oxidation reaction.2 
Herein we report the design of a system using thiol-thioester exchange as a means to effectively 
screen libraries of cyclic peptides against various quadruplex forming sequences in a high-
throughput fashion using dynamic combinatorial chemistry.  Thiol-thioester exchange is rapid in 
aqueous solution at neutral pH and provides a native-like linkage that is successively replaceable 
by a more robust amide or ester functionality.  Furthermore, cyclic peptides are advantageous 
because they mimic native protein structure, exhibit enhanced metabolic stability and are 
structurally preorganized thus reducing the entropic cost of binding.!!
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B.  Dynamic Combinatorial Experiments 
i. Optimization of Experimental Conditions 
For DCC to be compatible with nucleic acids, the building blocks as well as the library 
members need to be soluble in aqueous solution in the pH range of 5-8, which can be difficult to 
achieve with aromatic chromophores.  In the previously reported studies, the exchange reactions 
were carried out at pH 6.75 in NH4OAc buffer.  However, it was found that monomers 
containing the acridine ligand were not soluble under these conditions.  Therefore, various buffer 
conditions were screened, and it was found that 25 mM of Tris buffer at a pH of 7.4 was optimal.  
Additionally, the ideal concentration of potassium chloride (KCl) necessary to facilitate folding 
of the quadruplex structure needed to be determined.  A CD spectrum was taken of the cKit21 
sequence at various concentrations of KCl in 25 mM Tris buffer at pH 7.4.  It was desirable to 
use the least amount of KCl in the dynamic combinatorial experiments while still facilitating full 
folding of the quadruplex structure.  By comparison of the CD spectrums, it was determined that 
50 mM of KCl was the optimal concentration to run the dynamic combinatorial experiments as 
25 mM of KCl did not facilitate complete folding of the quadruplex structure, which can be seen 
by the decrease in the CD signal (Figure 4.1).  Initially, monomers were mixed in the absence of 
DNA to confirm that they behaved as expected and cyclized, forming a library of various species 
under the conditions previously determined.  Figure 4.2 shows that upon mixing three 
monomers, there was a mixture of monomers, homodimers, heterodimers and even trimers. 
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Figure 4.1 Circular dichroism spectra of cKit-21 (20 µM) at 25°C in 25 mM Tris pH 7.4 with 
varying concentrations of KCl.  
 
 
 
Figure 4.2 Chromatograph of dynamic combinatorial library at 280 nm.  Libraries equilibrated 
for 1 hour in 25 mM Tris buffer with 50 mM KCl at pH 7.4. 
 
 
ii. Dynamic Combinatorial Experiments 
The most common method used to detect and analyze the amplified products of DCC 
utilizes a biotinylated oligonucleotide target molecule that can be immobilized onto streptavidin-
functionalized magnetic beads by the strong biotin-streptavidin interaction.2 This allows ready 
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separation of the DNA from the DCL members. Upon removal of the supernatant, washing, 
denaturing the DNA and removing the beads, the compounds that were bound to the DNA are 
identified by LC/MS.  Similarly, we designed a system containing a DNA sequence with a biotin 
tag (Figure 4.3), allowing the library mixture to be added to streptavidin-coated beads to isolate 
the DNA from the library samples.  In the initial system we utilized streptavidin-coated agarose 
or Ultralink resins purchased from Fisher Scientific.  This system allowed library washes to be 
isolated by centrifugation through a fritted column.  After thorough rinsing at room temperature, 
the streptavidin beads could be heated to 80 °C to denature the DNA and thus release any bound 
library species.  Both washes could then be analyzed via LC/MS.   
 
Figure 4.3 Schematic of dynamic combinatorial experiments. A) DCC libraries equilibrated in 
the presence of quadruplex DNA attached to biotin B) Isolation of DCC libraries from DNA 
sample to allow for subsequent analysis by LC/MS. 
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Pierce Streptavidin Agarose Resin due to the cost efficiency and high loading of streptavidin.  
Initial screening resulted in incomplete recovery of the library members.  As shown in Figure 
4.4, the combined signals for the supernatant and denature washes did not equal the signal for the 
library in buffer in the absence of a DNA template.  In the effort to overcome this problem, the 
libraries were quenched with acetic acid rather than trifluoroacetic acid (TFA) since too much 
TFA often resulted in the DNA crashing out of solution.  In addition, different methods of 
heating were attempted in the denature step.  Initially denaturation was done by adding a hot 
solution of 0.1% TFA.  However, this seemed insufficient so heat resistant parafilm was used to 
seal the bottom of the columns so that they could be heated directly in a sand bath.  Also, 
different heating times were investigated from 10 minutes to 30 minutes, but none of these 
changes seemed to improve recovery of the library species.  Further screens with different 
monomers were completed and displayed the same problem, showing incomplete recovery of the 
library members.  However, despite seeing incomplete recovery of the library species, we did see 
amplification of the Ac-KCPW-SR dimer species in the presence of Htelo (Figure 4.5).  This 
result was encouraging, and we continued to work to optimize the experiment to determine what 
was happening to the library members.   
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Figure 4.4 Chromatograph of monomer Ac-WCPR-SR screened against quadruplex sequence 
Htelo at 280 nm.  Library equilibrated for 1 hour at 500 µM in 25 mM Tris buffer with 50 mM 
KCl at pH 7.4 at 25 °C. 
 
!!
Figure 4.5 Chromatograph of monomer Ac-KCPW-SR screened against quadruplex sequence 
Htelo at 280 nm.  Library equilibrated for 1 hour at 500 µM in 25 mM Tris buffer with 50 mM 
KCl at pH 7.4 at 25 °C. 
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 We had a number of theories for why we were not recovering all of the library members 
including: 1) The DNA was not being completely denatured, 2) The library members were 
interacting with the streptavidin beads and 3) the thioester bond was reacting with the DNA.  In 
the effort to circumvent the second problem, we attempted to carry out the experiments using 
Plus capacity Pierce Streptavidin Ultralink Resin that contains a polyacrylamide resin as opposed 
to agarose.  The dynamic combinatorial experiments were carried out the same way as before 
with the only difference being the resin used.  This seemed to result in improved, if not complete, 
recovery of the library members (Figure 4.6).  Dimeric as well as trimeric species were amplified 
while the monomeric species decreased.  Both of the dimeric and trimeric species were also 
pulled out in the denature wash.  However, some species were amplified that could not be 
identified. 
 Pleased with this result, we moved forward to incorporate monomers containing the 
acridine ligand at the N-terminus.  Following the same protocol and using the Plus capacity 
Pierce Streptavidin Ultralink Resin we screened three monomers containing the acridine ligand 
against the Htelo sequence.  Again however, we encountered issues with recovering all of the 
library members (Figure 4.7) as no species were recovered in the supernatant wash and less than 
half were recovered in the denature wash.  The concentration of the DCC screens was decreased 
to 100µM given the high binding affinity the acridine ligand has for the quadruplex structure.  
We rationalized that maybe having two ligands (once the monomers have dimerized) was too 
much, leading to non-specific interactions with the quadruplex DNA.  To correct for this, 
libraries containing acetyl-capped monomers were incorporated as well as those containing the 
acridine ligand at the N-terminus (Figure 4.8).  This also did not result in complete recovery of 
the library species.  It was interesting however, that most of the acetyl capped library members 
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were recovered while little to none of the library members containing the acridine ligand were 
recovered (Figure 4.8).  This led us to believe that the DNA was not being completely denatured, 
therefore some library species were remaining bound. 
   !
Figure 4.6 Chromatograph of monomer Ac-WCPR-SR screened against quadruplex sequence 
Htelo at 210 nm.  Library equilibrated for 1 hour at 500 µM in 25 mM Tris buffer with 50 mM 
KCl at pH 7.4 at 25 °C. 
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Figure 4.7 Chromatograph of monomers Lig-RCPF-SR, Lig-KCPF-SR and Lig-KCPS-SR 
screened against quadruplex sequence Htelo at 254 nm.  Library equilibrated for 1 hour at 100 
µM in 25 mM Tris buffer with 50 mM KCl at pH 7.4 at 25 °C. 
 
 
!
Figure 4.8 Chromatograph of monomers Lig-RCPF-SR, Ac-TCPR-SR and Ac-FCPR-SR 
screened against quadruplex sequence Htelo and dsDNA at 210 nm.  Library equilibrated for 1 
hour at 100 µM in 25mM Tris buffer with 50 mM KCl at pH 7.4 at 25°C.  Spectrums shown are 
the combination of the supernatant and denature washes.   
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 At this time, the libraries were also screened against dsDNA in addition to Htelo, cKit21 
and cMyc22 to determine if there is any selectivity.  Interestingly, in Figure 4.8, it appears that 
the dsDNA favors the monomers. However, nothing conclusive can be determined since not all 
of the library members in the screen were recovered.  Figure 4.9 shows screens of Lig-RCPF-SR, 
Ac-TCPR-SR, Ac-FCPR-SR against Htelo, cKit21 and cMyc22.  Despite not recovering all of 
the library members, there is little difference between chromatographs of the different 
quadruplex structures showing no specificity.   
 In the effort to recover all of the library members, the beads were washed with an organic 
solvent (95% MeCN, 5% H2O, 0.1% TFA) in an attempt to disrupt any electrostatic interactions 
between the DNA and positively charged monomers.  Once again, we did not see improved 
recovery of the monomers.  It was also hypothesized that we did not see full recovery of the 
library members due to incomplete denaturation of the DNA sample.  So, in the effort to aid in 
denaturation, the beads were washed with 1 mM of 18-crown-6.  By adding 18-crown-6, we 
hoped that the potassium ions would preferentially bind to the 18-crown-6 rather than the DNA 
thus effectively destabilizing the quadruplex structure.  A side-by-side comparison was done of 
heat denaturation at 80 °C versus the addition of 1 mM of 18-crown-6 at °C in the effort to 
recover library members.  As shown in Figure 4.10, the addition of 18-crown-6 at room 
temperature was not effective at denaturing the DNA and retrieving the bound library members. 
The DNA was then denatured by treating the streptavidin beads with 1 mM of 18-crown-6 in 
addition to mild heating at 50°C, but again, we did not see full recovery of the library members. 
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Figure 4.9 Chromatograph of monomers Lig-RCPF-SR, Ac-TCPR-SR and Ac-FCPR-SR 
screened against quadruplex sequence Htelo, cKit21 and cMyc22 at 210 nm.  Library 
equilibrated for 1 hour at 100 µM in 25mM Tris buffer with 50 mM KCl at pH 7.4.  Spectra 
shown are the combination of the supernatant and denature washes.   
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Figure 4.10 Chromatograph of monomers Ac-WCPR-SR screened against quadruplex sequence 
cKit21 and dsDNA at 210 nm.  Library equilibrated for 1 hour at 250 µM in 25 mM Tris buffer 
with 50 mM KCl at pH 7.4.  Top spectra in both chromatographs is the heat denaturation wash at 
80 °C while the in bottom spectrum the denaturation method is the addition of 1 mM 18-crown-6 
at 25 °C.  
 
Figure 4.11 Schematic of dynamic combinatorial experiments using streptavidin-coated 
magnetic beads.  
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 Dynamic combinatorial experiments were carried out under the protocol outlined in 
Figure 4.11 using the Streptavidin Magnetic Beads from New England Biosystems.  The 
experiments were performed at 250 µM in 25 mM Tris buffer at pH 7.4 with 50 mM KCl.  The 
libraries were allowed to equilibrate in the presence of the sequence Htelo.  After the supernatant 
was separated from the oligonucleotides bound to the magnetic beads, the DNA was denatured at 
80 °C.  Following analysis by LC/MS, it was determined all library members were covered, with 
the homodimers and heterodimer of monomers Ac-KCPW-SR and Ac-FCPR-SR being released 
in the denaturing wash (Figure 4.12).  Extremely pleased with this result, we repeated the 
experiment while also screening against the dsDNA sequence.  We were once again were able to 
recover all library members, with the same dimeric species being released in the denature wash 
when screening against the Htelo sequence.  Some of the same species were released in the 
denature wash against the dsDNA sequence, albeit in lower quantities.  Since it appeared that 
these cyclic octapeptide species were binding to the quadruplex structure of Htelo, we have 
begun preliminary binding studies utilizing thermal denaturation and SPR. 
 
Figure 4.12 Chromatograph of monomers Ac-FCPR-SR and Ac-KCPW-SR screened against 
quadruplex sequence Htelo at 210 nm.  Library equilibrated for 1 hour at 100 µM in 25mM Tris 
buffer with 50 mM KCl at pH 7.4 at 25°C. 
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C. Conclusions and Future Directions 
 Recent results have suggested that dimeric species of the peptide monomers bind with 
some affinity to the Htelo sequence specifically over duplex DNA.  Initial binding studies have 
been carried out by performing thermal denaturation experiments at 295 nm however; no change 
is seen in the presence or absence of the library members.  This could be due to the weak binding 
interaction of the DNA and library members or that the cyclic peptide provides no additional 
thermodynamic stability to the secondary DNA structure.  Future binding studies can be carried 
out using surface plasmon resonance (SPR) as a more direct means to determine the binding 
affinity of the cyclic peptide species.  Following a fragment based lead discovery, the small 
cyclic peptides that bind with weak affinity to G-quadruplex DNA can be combined with the 
acridine ligand to ideally provide a lead with even higher binding affinity.  Therefore, binding 
experiments can be carried out with the hits identified above containing only acetyl-capped 
monomers in addition to the cyclic peptide hits conjugated to the acridine ligand.  
 The dynamic combinatorial experiments proved to be more difficult to carry out than 
initially believed.  The type of streptavidin beads used was very important in order to prevent 
unwanted interaction of the library members with the beads.  Additionally, more recent data 
suggests that the temperature at denaturation is also important.  Another theory for incomplete 
recovery of the library members was reaction of the DNA with the thioester bond.  It is possible 
this occurs at elevated temperatures, close to 80 °C.  When the experiments were carried out at a 
slightly lower denaturation temperature of 70 °C, all members of the library could consistently 
be fully recovered.  However, we were unable to conclusively prove or disprove this theory.  
Having established a successful protocol for the DCC experiments, additional libraries can be 
screened for selectivity in the future, including those containing the acridine ligand.  
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D.  Experimental Procedure 
i. Oligonucleotides 
5’-biotinylated oligonucleotides were purchased from Integrated DNA Technologies at 
HPLC-purified quality.  Oligonucleotide samples were taken up in 1 mL of MilliQ purified water 
and UV/Vis was used to determine concentrations at 260 nm.  Concentrations were determined 
at 95 °C to ensure that oligonucleotides were completely denatured.  The concentration was 
determined using the molar extinction coefficient provided by Integrated DNA Technologies for 
each oligonucleotide sample.  250 µM stock solutions were made by transferring 150 nmol of 
each oligonucleotide to an eppendorf tube, freeze drying the sample, and reconstituting the 
oligonucleotide in 600 µL of 25 mM Tris buffer at pH 7.4 with 50mM of KCl.  In the case of the 
dsDNA, each of the complementary strands was freeze dried together.  Before use in the DCLs, 
the oligonucleotides were annealed by heating to 95 °C for 5 min, followed by slow cooling to 
room temperature.   
Gene Sequence 
Htelo /5Biosg/GTT AGG GTT AGG GTT AGG GTT AGG GTT AGG 
cKit-21 /5Biosg/CGG GCG GGC GCG AGG GAG GGG 
cMyc-22 /5Biosg/GGC ATA GTG CGT GGG CGT TAG C 
NRas /5Biosg/TGT GGG AGG GGC GGG TCT GGG TGC 
dsDNA /5Biosg/GGC ATA GTG CGT GGG CGT TAG C               CCG TAT CAC GCA CCC GCA ACG G 
 
Figure 4.13 Sequences of biotinylated oligonucleotides used in the dynamic combinatorial 
experiments.  
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ii. Circular Dichroism 
CD measurements were performed on a Chirascan Plus Circular Dichroism Spectrometer.  
CD data was obtained for each nucleotide sample at the concentration indicated in 25 mM Tris at 
pH 7.4 with 50 mM KCl.  Scans were performed at 25 °C from 320 – 220 nm (Figure 4.14).   
 
Figure 4.14 CD data for annealed sequences of Htelo, cMyc, cKit, and Nras.  CD data obtained 
at the concentration indicated in 25 mM Tris at pH 7.4 with 50 mM KCl.  Scans were performed 
at 25 °C from 320 – 220 nm.  Sequences cKit and Nras are parallel folded structures as indicated 
by a maximum at 260 nm and a minimum at 240 nm.  The sequence cMyc is an anti-parallel 
folded structure as indicated by a maximum at 290 nm.  Htelo is a mixed parallel and anti-
parallel folded structure indicated by two maximums at 260 nm and 290 nm. 
 
Thermal denaturation experiments were performed using the same buffer and 
concentrations as indicated.  Measurements were taken between 25 and 94 °C.  The melting 
curves were normalized to show the fraction folded using Eq. 4.1 where Θ0 is MRE, ΘD is the 
MRE for the fully denatured oligonucleotide, and ΘF is the MRE for initially folded 
oligonucleotide.   
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iii. DCC Experiments  
Monomer building blocks were stored as 5 mM stock solutions.  5 µL (25 nmol) was 
removed and freeze dried in an eppendorf tube for the DCC experiments.  Each DCL was 
prepared at a final volume of 100 µL and contained 250 µM of template (where appropriate) and 
250 µM of each peptide monomer in 25 mM Tris at pH 7.4 with 50 mM KCl.  The libraries were 
left to stand for 6 hours.  The mixtures were then acidified by adding 100 µL of a 0.1% TFA 
solution in water in order to halt thiol-thioester exchange. DNA templates were removed before 
UV-HPLC-MS analysis. For each DCL, the library mixture was added to 1 mL of streptavidin-
coated magnetic beads (Streptavidin Magnetic Beads, 4 mg/mL suspension, New England 
Biolabs, Inc.) that had been washed repeatedly with 0.1% TFA in water (5×200 µL).  The beads 
and library mixture were incubated for 15 minutes, the beads were retained in the vessel using a 
magnet, while the supernatant was pipetted off. The beads were washed with a solution of 0.1% 
TFA in water (3×200 µL) at room temperature followed by a hot solution of 0.1% TFA in water 
(incubation at 70 °C for 15 min, 3×200 µL). The solvent was removed in vacuo. The residue was 
redissolved in a solution of 0.1% TFA in water (50 µL) and analysed by UV-HPLC-MS.  
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CHAPTER 5: INTRODUCTION 
SIGNIFICANCE OF HISTONE MODIFICATION  
AND TRIMETHYLATED LYSINE 
 
A. Significance of This Research 
Epigenetics is the study of changes in the genetic expression that do not involve altering 
the underlying nucleotide sequence.1 As such, epigenetics has become a major challenge in 
understanding the mechanisms of how genetic information is controlled.  Accumulating evidence 
has shown that post-translational modifications (PTMs) are a key component in controlling gene 
expression.2 A number of different modifications have been documented, including 
phosphorylation of serine and threonine, methylation of lysine and arginine, and acetylation of 
lysine, which act as chemical switches to stimulate or inhibit protein-protein interactions.3-5 More 
specifically, we are interested the methylation of lysine at the N-terminal tail of histones, which 
is a covalent modification shown to be intricately involved in DNA packaging and may directly 
control levels of gene expression.6 Therefore, there is a great effort to understand how 
recognition domains within the effector proteins that read these covalent modifications.  Gaining 
a greater understanding for the noncovalent interactions that dictate biomolecular recognition 
will provide better insight into the histone lysine methylation effect and will also aid in the 
development of inhibitors of these interactions.   
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B. DNA Packaging 
The entire genomic DNA is complexed with a mass of proteins, forming a large 
macromolecular assembly known as chromatin.7,8 This macromolecular assembly effectively 
compacts the genomic DNA 10,000-fold and packages it into well-organized higher structures, 
maintaining accessibility for replication and transcription. The basic building block of the 
chromatin is the nucleosome, which is comprised of four subunits H2A, H2B, H3, and H4 that 
dimerize to make up the histone octomer (Figure 5.1).  Approximately 147 base pairs of DNA 
are wrapped around this basic octomeric protein complex.  A fifth histone, the linker histone H1, 
keeps the DNA in place and interacts with the linker DNA, which is the DNA that connects two 
nucleosomes.9,10 The entire macromolecular assembly, made up of the histone subunits and the 
DNA, was found to form a disk-like shape with an approximate diameter of 100Å as determined 
by X-ray diffraction.11   
 
Figure 5.1 Nucleosome structure with DNA wrapped around the histone.  Histone colors are 
indicated and an example of the histone tail is boxed in.9 
 
 
 
 
 
Histones are obligate heterodimers in solution (Figure 3.1). Despite their rela-
tively similar structures especially in the histone fold regions, the four core his-
tones are very exclusive in the types of interactions they form. H2A only dimerizes
with H2B, and H3 only dimerizes with H4. This selectivity is explained by the
large dimerization interface via a “handshake motif,” allowing for exquisite
complementation of side chains between the subunits [14]. In solution, H2A and
H2B exist as het rodimers (Figure 3.1a). When refolded i vitro under reasonably
high concentrations and in the absence of interacting factors, H3 and H4 forms a
(H3-H4)2 tetr mer that can best be described as a dimer of two H3-H4 dimers
(Figure 3.1b). The interface between the two H3-H4 dimers (which is much
smaller than any of the interfaces forming the histone fold dimers) is mediated by
numerous salt bridges and hydrogen bonds that are part of a four helix bundle
structure. H2A-H2B dimers and (H3-H4)2 tetramers do not interact with each
H2A-H2B/DNAH3-H4/DNA
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Figure 3.2 The nucleosome is a modular
assembly. (a) Structure of the nucleosome,
viewed down the superhelical axis. The
nucleosomal dyad (that is, the central base
pair) is indicated. Histone colors are as
indicated. (b) Half of the DNA and associated
proteins are shown in the same view as in
(a). The penultimate 15 bp of DNA are
organized by the aN helix of the second H3
chain (not shown). The points of interaction
with histones are numbered 0.5–6.5. The two
arrows indicate an example for a highly
expanded and narrowed major groove,
respectively. (c) The histone fold dimer of H3-
H4 organizes 30 bp of DNA. Key amino acids
involved in the interaction with the DNA are
shown in red, points of interaction between
DNA and protein are labeled as in (b).
(d) H2A-H2B dimer and its associated DNA
are shown in the same orientation as in (c).
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C. Significance of Histone Modification 
Epigenetics is the study of relevant modifications to the genome that do not involve 
change in the nucleotide sequence.12 Examples of such changes to the genome involve DNA 
methylation, which can silence gene expression and covalent post-translational modifications 
(PTMs) of proteins including histones, chromatin remodeling proteins, and transcriptional 
regulators.13,14 Both of these examples serve to regulate gene expression without altering the 
underlying DNA sequence.  Consequently, non-genetic factors can cause an organism’s genes to 
behave or express themselves differently. Recently, it has been realized that each of these 
regulatory mechanisms are interconnected, resulting in additional levels of complexity. 
Anomalous regulation of these mechanisms have been linked with a variety of diseases such as 
autoimmune diseases and cancer.15 Therefore, it is important to increase our understanding of the 
mechanism and biological impact of these epigenetic regulators so we can gain a better 
understanding of cellular growth, development and human diseases.   
The N-terminus of each core histone protein is largely unstructured, making up 20% of 
the total amino acids of the histone proteins and protruding from the globular core of the 
nucleosome.  This section of the histone is referred to as the histone tail, and accounts for the 
majority of variability in post-translation marks between species.  These sequences are highly 
conserved amongst eukaryotes and are made up of mostly positively charged residues resulting 
in favorable electrostatic interaction with the sugar-phosphate backbone of DNA.16 The histone 
tails are known to interact with a variety of proteins, influencing biological processes involving 
transcription, replication, and chromosome maintenance.  A number of different modifications 
have been documented, including phosphorylation of serine and threonine, methylation of lysine 
and arginine, and acetylation of lysine amongst others.3-5   
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i. Lysine Methylation on Histones 
Methylation is one of the most abundant covalent PTM of the histone and is the focus of 
this research.  The methylation of the histone is one of the most complex and least understood of 
the covalent modifications, likely due to the numerous levels of possible methylation states of 
lysine and arginine including mono-, di-, and trimethylation with each methylation state affecting 
DNA expression differently.6 Consequently, methylation is site specific and can be associated 
with both activation and repression of gene expression.  
 
Figure 5.2 Various methylation states of lysine and arginine.  Dimethylarginine can exist in the 
symmetric (s) and asymmetric (a) form.   
 
The methylation of lysine residues within the histones is tightly regulated by 
methyltransferases (KMTs) and demethylases (KDMs), resulting in maintenance of cell fate and 
genomic stability.  KMTs and KDMs are very specific for a particular residue and the degree of 
methylation on that residue.  Almost all KMTs contain an enzymatic SET-domain, with some 
acting exclusively as mono-, di-, or trimethyltransferases, whereas others can carry out all three 
methylastions in the presence of S-adenosylmethionine (AdoMet) as the methyl-donating 
cofactor.6 The degree of methylation is dependent on the size of a narrow channel termed the 
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“methylation” core, while site specificity is dictated by H-bonds to amino acids surrounding the 
lysine substrate. 
 
Figure 5.3 Mechanism of lysine 9 methylation catalyzed by the SET7/9 with the cofactor 
AdoMet.  Histone lysine is highlighted in red.  AdoMet is highlighted in blue and is converted to 
S-adenyl homocysteine (AdoHcy).  The SET7/9 residues are shown in black. 
 
More recently, understanding regarding lysine demethylation has been greatly enhanced 
through structural analysis.  It was previously believed that methyllysine was an irreversible 
modification that required phosphorylation of a neighboring amino acid to reverse the effects of 
the methyl mark.  However, structural analysis has identified key interacting partners and amino 
acids in KDMs that are responsible for their activity and specificity.  For example, structures of 
the JmjC catalytic domain revealed that it consists of a β-barrel structure that coordinates Fe(II) 
and α-ketoglutarate.18,19 In addition, KDM4A interacts with the methylated lysine via amino 
acids within a specific β-sheet in the β-barrel structure and are predicted to impact the degree of 
demethylation.20   
Modifications to histone proteins transmit biological information through local binding 
factors that recognize distinct modifications on specific residues.21 Numerous reports have 
described methylated histone lysine binding proteins, also known as ‘effector’ modules.22 The 
chromodomain has been identified in numerous chromatin-associated proteins and has been 
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shown to be specific for methylated lysines in certain instances.  The binding affinities of 
chromodomains for their respective modified lysines have been shown to be relatively weak (KD 
~ 10-4 – 10-6), which are thought to allow for rapid ‘on-off’ binding.21 The chromodomain is part 
of a family of methylated lysine recognition domains also containing tudor, MBT and PWWP 
that are collectively known as the ‘royal family.’ All proteins containing domains of the “royal 
family” are implicated in chromatin and genetic control.23 
ii.  Lysine 9 of Histone H3 Tail 
Lysine 9 methylation of histone H3 is catalyzed by a number of different enzymes 
including human Suv39h, G9a, ESET, and GLP/Eu-HMTase1.  The methylation of H3K9 has 
been linked to the inhibition of H3/H4 acetylation, and H3K4 methylation, all of which are 
marks of active chromatin, suggesting that H3K9 methylation may define transcriptionally 
inactive chromatin.24,25 Cross talk also occurs between H3K9Me3 and other histone 
modifications, including phosphorylation of H3 serine 10, leading to more complicated 
regulation in cellular function.  
HP1 is a reader protein that is highly selective for H3K9Me3 over other methylated 
lysine marks, such as H3K4Me3.  The HP1 protein contains a chromodomain that is responsible 
for proper recognition and binding of H3K9Me3. The recognition of H3 trimethylation by the 
chromodomain of HP1 has been link to transcriptional repression via heterochromatin 
formation.26,27,11 Therefore, accurate targeting of HP1 via its chromodomain is necessary for the 
maintenance of proper chromatin function. The interaction of these two proteins is critical for the 
control of gene expression and the maintenance of a stable genome during cell development.28   
Structures of HP1 bound to H3K9 di- and trimethylated peptides reveal an aromatic cage 
of three residues that binds the methyl ammonium group.29,30 The structure shows a binding 
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pocket made up of 5-10 residues of the HP1 chromodomain that participate directly in the 
binding to the H3 histone tail.  The trimethylated lysine sits in the binding pocket, equidistant 
from the aromatic face of two tyrosine residues and a tryptophan.  This strongly suggests that 
recognition of H3K9Me3 by the aromatic cage of the HP1 chromodomain is governed by cation-
π interactions.  The cation-π interaction is defined by the attractive interaction between a 
positively charged moiety and the π electrons of the aromatic ring.31 Recognition of 
trimethyllysine via cation-π interaction was further confirmed by studies showing that mutation 
of each of the aromatic residues to an alanine resulted in a dramatic reduction in binding 
affinity.29 Additionally, previous studies in our lab demonstrated that substitution of the cationic 
methyl ammonium group with a neutral tert-butyl group resulted in a binding affinity that was 
reduced 31-fold.32  This was a surprising result given the similar size and increased 
hydrophobicity of the neutral t-butyl group compared to the trimethyl ammonium moiety.  This 
study however, further demonstrates the importance of the cation-π interaction in the recognition 
of trimethyllysine by the HP1 chromodomain.   
 
Figure 5.4 Aromatic cage of HP1 chromodomain formed by two tyrosines and one tryptophan 
bound to trimethyllysine. 
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D. Purpose of This Work 
Lysine can exist in three distinct methylation states under the control of highly specific 
methyl transferases or demethylases.  These methylation states serve to turn on specific protein-
protein interactions with partners that specifically recognize the methylated side chain.  These 
interactions are implicated in diverse cellular processes, but are most closely associated with 
gene regulation pathways and dysregulation leads to a number of diseases, including some types 
of cancers.  More recently, it has been documented that these effector proteins engage 
methylated amino acids via an aromatic cage.  Recognition and affinity is mainly derived from 
cation-π interactions between the positively charged cationic side chain and the electron rich π 
surfaces of nearby aromatic rings.  It is the goal of this work to study how much the cation-π 
interaction contributes to the binding of the HP1 chromodomain to trimethylated lysine 9 of 
histone 3 (H3).  This interaction can be quantified by incorporation of fluorinated derivatives of 
the aromatic amino acids responsible for the binding of H3K9Me3 to the HP1 chromodomain.  
The cation-π interaction between the aromatic pocket of the HP1 chromodomain and H3K9Me3 
can be revealed by incorporation of a series of fluorinated amino acid analogues.  A linear 
correlation between binding affinity and the calculated magnitude of the cation-pi interaction of 
those groups indicates a cation-π interaction.  By carrying out these studies, we hope to gain 
more information regarding the noncovalent interactions responsible for the biomolecular 
recognition of H3K9Me3 by aromatic pocket of the HP1 chromodomain.  Because many reader 
proteins for methylated lysine have an aromatic cage in their binding pockets, findings from the 
investigation of the HP1 chromodomain will provide broad insight into this class of proteins.   
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CHAPTER 6: PROBING THE ROLE OF CATION-π  
INTERACTIONS USING UNNATURAL AMINO ACIDS 
 
A. Background !
The cation-π interaction is an important force in molecular recognition and protein 
structure.1 Furthermore, it has been established that the cation-π interaction is an important 
element in the recognition of the methylated amino acids through interaction with the aromatic 
pocket of effector proteins.2-4 The cation-π interaction includes a substantial electrostatic 
component as the Cδ--Hδ+ bond dipoles of the aromatic ring produce a region of negative 
electrostatic potential on the face of the π system (Figure 6.1a).5 Electrostatics dictates a natural 
attraction of cations to the surface.  By incorporating fluorinated amino acids, there is a 
deactivating effect for a cation-π interaction due to electron density being withdrawn from the 
ring by the fluorine atoms.6 However, the addition of fluorine atoms results in little perturbation 
in the sterics of the residue.  The energetic contribution of this interaction can be systematically 
probed through progressive fluorination of the aromatic ring (Figure 6.1b and c), which has an 
additive effect on the cation-π binding ability of the ring.  The purpose of this research is to 
determine the role of aromatic cage of the HP1 chromodomain in its binding to trimethyl lysine 9 
of histone 3 (H3 K9Me3).  If the binding of a residue to trimethyllysine is governed by cation-π 
interactions, there will be a linear correlation between the attenuation of the potential cation-π 
ability of the residue by fluorination and strength of binding to trimethyllysine.7,8   
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Figure 6.1 Electrostatic potential maps with red regions being the most electron-rich regions of a 
molecule and blue regions of a map being the most electron-poor regions of a molecule. A) 
Interaction of benzene with an ammonium cation.  B) Electrostatic maps of the sidechains of 
tyrosine and tetrafluorotyrosine.  C) Electrostatic potential maps of the sidechains of tryptophan, 
difluorotryptophan and tetrafluorotryptophan. 
 
Dougherty et al. has used this fluorinated amino acid methodology to probe the role of 
the cation-π interaction in nicotinic acetylcholine receptors (nAChRs).9 The nicotinic 
acetylcholine (ACh) receptor is a neurotransmitter-gated ion channel that contains a number of 
aromatic amino acids that have been identified as contributing to the recognition of 
acetylcholine.  The presence of these aromatic residues at the binding site suggests that cation-π 
interaction may be involved in binding the ammonium group of acetylcholine (Figure 6.2a).  
Consequently, the role of the cation-π interaction was quantitated through the incorporation and 
electrophysiological evaluation of a series of fluorinated Trp derivatives at four sites of the 
mouse muscle nAChR.  All of these sites naturally contained Trp and all had been implicated in 
binding to ACh.  At three of these sites, incorporation of the tetrafluorotryptophan gave EC50 
values for ACh that were not very different from the wild type, ruling out a strong cation-π 
a b 
c 
Tyr F4Tyr 
Trp 2FTrp 4FTrp 
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interaction.  However, progressive fluorination at position α149 led to a systematic increase in 
the EC50.  Dougherty et al. revealed that fluorination at position α149 resulted in a direct 
correlation between EC50 and calculated cation-π ability.  This provided compelling evidence 
that the quaternary ammonium group of ACh makes close contact with the side chain of αTrp-
149 in the nAChR via cation-π interactions.   
 
Figure 6.2 A) Structure of acetylcholine. B) Plot of log[EC50/EC50(wild type)] vs. quantitative 
cation-π binding ability at α149. 
 
 
B. Peptide Design and Synthesis 
 The binding of the HP1 chromodomain to trimethyl lysine 9 on the H3 histone tail is an 
important interaction necessary for the maintenance of proper chromatin function.  The 
deregulation of this interaction has been implicated in a number of disease states.  In the effort to 
further probe the role the cation-π interaction plays in the recognition of trimethyl lysine, we 
aimed to carry out experiments similar to those done by Dougherty, incorporating fluorinated 
aromatic acids into the aromatic cage of the HP1 chromodomain. Gaining a greater 
O
O N
a 
b 
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understanding for the noncovalent interactions that dictate biomolecular recognition will provide 
better insight into the histone lysine methylation effect.  Additionally, by incorporating 
fluorinated amino acids into the aromatic binding pocket of the HP1 chromodomain, we can 
perform assays to determine the influence on the binding of inhibitors designed by the Frye 
group. 
We proposed to accomplish this through the chemical synthesis of residues 22-76 of the 
HP1 chromodomain.  Throughout the chemical synthesis of the HP1 chromodomain fragment, 
Fmoc protected derivatives of fluorinated amino acids can be site specifically incorporated via 
traditional solid phase synthesis.   
i.  Native Chemical Ligation 
Despite the fact that much advancement has been made in the field of chemical protein 
synthesis, the large-scale production of longer peptides (>50 residues) introduces problems not 
yet resolved by traditional solid phase peptide synthesis.  The reiterative nature of solid phase 
peptide synthesis often results in a complex mixture of deletion products, lowering the overall 
yield and making the purification and isolation of the desired product difficult. Consequently, the 
ligation of fully unprotected peptide fragments offers significant advantages over the linear 
synthesis of longer peptide sequences.   
Native chemical ligation has revolutionized the field of peptide chemistry and is the most 
widely used ligation strategy.10 Native chemical ligation involves the reaction of unprotected 
thioesters with N-terminal cysteine peptides (Figure 6.3).  The reaction is chemoselective, 
making it applicable to the ligation of fully unprotected peptides under aqueous conditions.  The 
chemoselective step involves the reversible thiol-thioester exchange of the nucleophilic thiol of 
the Cys residue located at the N-terminus of the C-peptide and a thioester at the C-terminus of 
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the N-peptide.  The Cys-thioester subsequently undergoes a rapid intramolecular S→N acyl 
transfer via a favorable five-membered transition state to form a native peptide bond.  
 
Figure 6.3 Mechanistic aspects of the native chemical ligation. 
 
 
ii.  Synthesis of HP1 Chromodomain 
Using the technique of native chemical ligation, we proposed the chemical synthesis of 
the HP1 chromodomain (residues 22-76) out of the two shorter.  We chose to split the sequence 
between residues 37 and 38 for several reasons.  Residue 37 is Gly, which is the preferential 
terminal amino acid in the thioester fragment due to its greater reactivity than more sterically 
hindered thioesters.  For the C-terminal fragment, we proposed to use SPPS to make the 
sequence consisting of residues 38-76, in which methionine (Met) at residue 38 was mutated to a 
cysteine, as shown in Figure 6.4.  The proposed sequence is shown in Figure 6.4, with the 
residues in the aromatic cage highlighted in blue.  This site was chosen for mutation due to the 
location of the residue away from the binding pocket and in a solvent-exposed position, thereby 
minimizing overall structural changes in the protein.   
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Peptide Sequence 
HP1 (wt) Ac-EEYAVEKIIDRRVRKGMVEYYLKWKGYPETENTWEPPENNLDCQDLIQQYEASRKD-NH2 
HP1 22-37 
(thioester) 
Ac-EEYAVEKIIDRRVRKG-thioester 
HP1 38-76 
(M38C) 
CVEYYLKWKGYPETENTWEPPENNLDCQDLIQQYEASRKD-NH2 
 
Figure 6.4 Sequence of the wild type HP1 chromodomain, residues 22-76 and ligation sequence 
with ligation site highlighted in red (M38C). Residues located in aromatic cage are highlighted in 
blue. 
 
 
 Ligation fragments were synthesized using traditional solid phase peptide synthesis 
(SPPS).  Initial efforts to synthesize both peptide fragments resulted in the aspartimide 
formation, which is one of the most common undesirable side reactions in Fmoc-SPPS (Figure 
6.5).11 Aspartimide formation is the result of nucleophilic attack from the amide nitrogen of the 
preceding residue onto the β-carboxy group of aspartic acid (Asp).  Normally the β-carboxy 
group on the side chain of Asp is protected as an ester, thereby behaving as a leaving group in 
this side reaction.  The side reaction can be detected as the [M-18]+ ion by mass spectrometry.   
 
 
Figure 6.5 Formation of aspartimide. 
 
 
 A number of factors can affect aspartimide formation.  The stability of the Asp residue 
can vary in the presence of various secondary and tertiary amines.   Piperidine, the standard 
secondary amine applied in the removal of Fmoc in SPPS, gives rise to a considerably higher 
percentage of aspartimide formation.  By using the weaker secondary amine, piperazine, we were 
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able to help minimize aspartimide formation.  Furthermore, the addition of N-hydroxylamine-
based additives can contribute to the prevention of aspartimide formation.12 The acidic properties 
of N-hydroxylamines help to prevent aspartimide formation through acidic buffering of the 
solution.  The deprotonation of the Asp-X amide backbone is the critical step in cyclization that 
leads to aspartimide formation.  Therefore, when HOBt is used as an additive, conversion to its 
anion by the base decreases the amount of negatively charged amide backbone nitrogen, which is 
responsible for aspartimide formation.  By using a combination of piperazine and HOBt as an 
additive in the Fmoc deprotection step, we were able to successfully avoid aspartimide 
formation.   
The fragment containing the N-terminal Cys residue was synthesized easily on CLEAR-
amide resin using the Thuramed Tetras synthesizer.  The thioester fragment however, proved to 
be more difficult to synthesize.  Similar to the procedure described in Chapter 3, the thioester 
fragment was synthesized on 2-chlorotrityl chloride resin and elongated using Fmoc-SPPS.  For 
conversion to the thioester, the fully protected peptide must be cleaved from the resin, converted 
to the thioester, and then deprotected.  The cleavage of peptide from the resin proved to be 
problematic, however.  Initially, the fully protected peptide was cleaved 3x 3 minutes with 3 mL 
of 1% TFA in CH2Cl2 followed by formation of the thioester using PyBOP, DIPEA and 
methylthioglycolate in DMF.  Under these cleavage conditions, the resulting product was less 
polar than expected based on its retention time by HPLC and had a mass significantly larger than 
expected.  It was believed that the tert-butyl groups were being deprotected from the carboxylic 
group of aspartic acid and glutamic acid under the TFA conditions for cleavage.  The decrease in 
polarity was then hypothesized to result due to subsequent conversion of these free carboxylic 
acid groups to thioesters.  In order to avoid this side product, the cleavage conditions were 
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switched to a milder 1:1:8 mixture of acetic acid, trifluoroethanol and dichloromethane.  Under 
these cleavage conditions however, the protected peptide was insoluble in DMF as well as 
CH2Cl2 and therefore unable to be converted to the thioester.  We believed that cleavage with 
TFA aided in solubility due to the formation of TFA salts in the peptide.  To overcome the 
solubility problem, the peptide was cleaved for shorter periods at 5x 1 minute with 3 mL of 1% 
TFA in CH2Cl2.  The shorter washing times ensured that the tert-butyl groups remained on the 
carboxyl groups of the aspartic acid and glutamic acid side chains, resulting in good yield of the 
desired peptide thioester with no evidence for the higher mass products that had been obtained 
initially. 
 
C.  Future Directions 
Following synthesis of both fragments, the native chemical ligation can be carried out.13 
This will be done under buffered conditions at pH 7 in the presence of 4-mercaptophenylacetic 
acid (MPAA), which acts as a thiol catalyst, and tris(2-carboxyethyl)phosphine (TCEP).  TCEP 
is added as a reducing agent to prevent the formation of disulfides during the native chemical 
ligation.  After the conditions have been determined for the native chemical ligation, we can 
proceed with the incorporation of fluorinated amino acids into the sequence of the HP1 
chromodomain.  
The aromatic amino acids present in the aromatic pocket of the HP1 chromodomain are 
two tyrosine residues and a tryptophan.  We are working to incorporate fluorinated derivatives of 
tryptophan as well as fluorinated derivatives of tryrosine (Figure 6.6).  However, there are 
concerns that the progressive fluorination of tyrosine would perturb the pKa of the phenolic 
hydrogen. If the pKa is altered, progressive fluorination may affect more than just the cation-π 
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ability of the aromatic ring.  To avoid this, we hope that methyltyrosine would serve as a viable 
substitute (Figure 6.6).  
 
 
Figure 6.6 Electrostatic potential maps comparing Tyr and MeTyr as well as fluorinated Tyr and 
MeTyr.  Red regions represent the most electron-rich regions of a molecule and blue regions of a 
map are the most electron-poor regions of a molecule. 
 
 Following synthesis of the fluorinated derivatives of the extensive structural and 
functional studies will be performed.  Structural studies can be performed using circular 
dichroism to monitor the folding of the peptide.   And finally, binding studies will be done with 
all derivatives of the HP1 chromodomain to probe the effect of fluorination on the cation-π 
ability of the aromatic pocket in binding to trimethyllysine.  In collaboration with the Frye lab, 
we hope to use the information gained in the functional studies for the development of inhibitors 
for this interaction.   
 
 
 
Tyr F4Tyr 
MeTyr F4MeTyr 
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D. Experimental Procedure 
Solvents were of HPLC or reagent grade quality and purchased commercially from 
Sigma-Aldrich. Starting materials were purchased commercially from Fisher Scientific unless 
otherwise noted and used without further purification.  
Synthesis thioester fragment 9-Fluorenylmethoxycarbonyl (Fmoc) protected amino acids 
and HBTU and HOBt were purchased from Advanced Chemtech.  PyBOP was purchased from 
Novabiochem. 2-Chlorotritylchloride resin was purchased from ChemPep.  The glycine was 
preloaded onto 2-chlorotrityl resin (0.1 mmol).  Resin was activated with 1mL of thionyl 
chloride in 9 mL of CH2Cl2 for 1 hour in a peptide flask and bubbled with nitrogen.  The glycine 
was loaded onto the resin with DIPEA (8 equiv) and Fmoc-glycine (2 equiv) in CH2Cl2 for one 
hour, two times while being bubbled with nitrogen.    The remaining portion of the peptide was 
synthesized by automated solid-phase synthesis on a Thuramed Tetras peptide synthesizer 
(version X94) using Fmoc protected amino acids. Activation of amino acids was performed with 
HBTU and HOBT in the presence of DIEPA in DMF. Peptide deprotection was carried out in 
2% piperazine and 2% HOBt in DMF for approximately 15 min. Double coupling cycles (60 min 
each) were used for each amino acid coupling step. Peptides were manually acetylated at the N-
terminus with 5% acetic anhydride and 6% lutidine in DMF for 30 min. Cleavage of the peptide 
from the resin was performed in 3 mL of 1% TFA in dry dichloromethane at five times for 1 
minute.  The filtrate was concentrated by rotary evaporation to obtain the cleavage product as a 
yellow oil. The product was dried under high vacuum and then was dissolved in 3.6 mL of dry 
DMF. To that solution was added 40 µL N,N-Diisopropylethylamine (DIPEA), 22 µL methyl 
thioglycolate, 86 mg PyBOP and the reaction was stirred under N2 at room temperature for 1 h. 
DMF was removed under high vacuum to obtain yellow oil.  After formation of the thioester the 
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peptide was globally deprotected using 95:2.5:1:2.5 trifluoroacetic acid (TFA): water: 
triisopropylsilane (TIPS): ethanedithiol (EDT) for 4 h. TFA was evaporated and cleavage 
products were precipitated with cold ether. The peptide was extracted into water and lyophilized. 
It was then purified by reverse-phase HPLC, using a C-18 semipreparative column and a 
gradient of 0 to 100% B over 50 min, where solvent A was 95:5 water:acetonitrile, 0.1% TFA 
and solvent B was 95:5 acetonitrile:water, 0.1% TFA. After purification, the peptide was 
lyophilized to powder and identified with ESI-TOF mass spectroscopy.  
N-terminal cysteine fragment Peptide was synthesized by automated solid-phase 
synthesis on a Thuramed Tetras peptide synthesizer (version X94) on CLEAR-amide resin (0.1 
mmol) purchased from Advanced Chemtech using Fmoc protected amino acids. Activation of 
amino acids was performed with HBTU and HOBT in the presence of DIEPA in DMF. Peptide 
deprotection was carried out in 2% piperazine and 2% HOBt in DMF for approximately 15 min. 
Double coupling cycles (60 min each) were used for each amino acid coupling step.  Peptide was 
globally deprotected and cleaved from the resin using 95:2.5:1:2.5 trifluoroacetic acid (TFA): 
water: triisopropylsilane (TIPS): ethanedithiol (EDT) for 4 h. TFA was evaporated and cleavage 
products were precipitated with cold ether. The peptide was extracted into water and lyophilized. 
It was then purified by reverse-phase HPLC, using a C-18 semipreparative column and a 
gradient of 0 to 100% B over 50 min, where solvent A was 95:5 water:acetonitrile, 0.1% TFA 
and solvent B was 95:5 acetonitrile:water, 0.1% TFA. After purification, the peptide was 
lyophilized to powder and identified with ESI-TOF mass spectroscopy.  
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